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Moderate og alvorlige hodeskader omfatter pasienter med ytre skade mot hodet og tydelig 
påvirket bevissthet i akuttfasen. Dette er en sammensatt pasientgruppe der resultatet varierer 
fra død eller alvorlig funksjonshemming til fullstendig restitusjon. Det eksisterer få studier 
der man over tid har fulgt en fullstendig kohort av pasienter uten stort frafall.  
Formålet med studiene i denne avhandlingen var å studere funksjon hos en fulltallig gruppe 
av personer som 3-8 år tidligere var behandlet for alvorlig hodeskade ved St. Olavs Hospital. 
Videre ønsket vi å etablere en pasientdatabase for forskning innen moderat og alvorlig 
hodeskade ved St. Olavs Hospital. Med utgangspunkt i den ville vi, i denne avhandlingen, 
spesielt studere MR funn i tidlig fase etter hodeskaden samt grad av kognitiv reduksjon etter 
tre måneder.  
 
Avhandlingen består av fire delarbeider. 
 
I artikkel I studerte vi forekomsten av funksjonshemming, arbeidsuførhet og epilepsi blant 
94 personer (1-88 år), 3 til 8 år etter at de ble behandlet for alvorlig hodeskade. Et hovedfunn 
var at bare 1/3 hadde fått en alvorlig funksjonshemming etter skaden, slik at de trengte 
personhjelp i dagliglivet. Det var også i denne gruppen vi fant de fleste tilfellene av epilepsi. 
Derimot hadde ca 2/3 falt ut av det ordinære skole- og arbeidsliv. Bevissthetstilstand fire 
uker etter hodeskaden kunne i noen grad forutsi dette. 
Artikkel II og III omhandler en gruppe på 106 pasienter fra pasientdatabasen som hadde 
fått utført MR undersøkelsene i løpet av de fire første ukene. Alle unntatt én pasient hadde 
tegn til skade i hjernevevet, og ca 70 % hadde diffus aksonal skade. Diffus aksonal skade 
medførte mer påvirket bevissthet rett etter skaden, men var ikke i seg selv forbundet med 
dårligere funksjon ett år etter. Ved dobbeltsidig skade i hjernestammen var det stor fare for 
alvorlig funksjonshemming etter skaden. Skader sentralt i hjernen var en negativ prognostisk 
faktor hos pasienter med alvorlig hodeskade, men ikke hos de som hadde moderat hodeskade. 
Alder var en svært viktig negativ prognostisk faktor ved moderat hodeskade. 
Artikkel IV beskriver kognitiv funksjon tre måneder etter hodeskaden hos 63 personer med 
hodeskade sammenliknet med friske personer. Som gruppe hadde de med hodeskade 
redusert kognitiv funksjon, særlig på tester som krevde hurtig bearbeidelse av informasjon.  
Redusert kognitiv funksjon ved 3 mnd var også relatert til det å ha plager eller 
funksjonshemming ett år etter skaden. På den annen side presterte mange i pasientgruppen 
normalt bedømt ut i fra de normene som brukes i klinisk arbeid. Nesten halvparten av de 
med normal funksjon hadde plager eller funksjonshemming relatert til hodeskaden ved ett 
års oppfølging. Dette aktualiserer spørsmålet om hvorvidt vanlige nevropsykologiske tester 
er sensitive nok for å evaluere effektene av hodeskader.  
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Foreword 
 
During my work for fifteen years in the field of brain injury rehabilitation, I have 
got many questions. How is it going to be? Is this problem typical? Or expected? 
Questions came from our patients, but also their families, other professionals, 
lawyers, the Court and insurance companies. And through my work, I gathered 
experience.  
But, inevitably, I collected my experience to a large extent from the individuals 
who I saw most, and those were person who struggled and who in periods needed 
much support from our specialized rehabilitation facility. And thus, without really 
knowing, my view of traumatic brain injury became biased. 
 
Through the Head Injury Project, we have had the unique possibility to get in 
touch with all the persons that were treated for moderate and severe head injuries at 
this hospital for a long time period. This has increased our understanding of the 
consequences of head injury. It has shown us a great variation in outcomes, and also 
that many of those who sustain a traumatic brain injury recover well or cope well 
with the effects of the injury.  
Hopefully, in the years to come, we may be able to answer the questions from 
our patients and those around them more precisely and, more important; improve our 
services.  
 
I am deeply grateful to all those who consented to participate in the project; our 
patients and their families.  Their trust and effort made this possible. 
 
Thanks!
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SUMMARY 
Traumatic brain injury (TBI) is a diagnosis comprising a heterogeneous group of 
patients. A TBI may be categorized as mild, moderate or severe depending on the 
level of consciousness after the trauma. It is generally accepted that individuals with 
moderate and severe TBI may experience long-lasting disability, but the frequency 
and magnitude of cognitive impairments or disabilities are not well described in 
neurosurgical cohorts that also include moderate injuries. Furthermore, there are few 
prospective, longitudinal follow-up studies describing early MRI findings.  
The objective was to describe early MRI findings as well as the short-term and 
long-term consequences in samples of individuals with moderate and severe head 
injury. Furthermore, we sought to study risk factors for disability and epilepsy. We 
aimed at emphasizing a clinical approach, regarding methods as well as 
interpretation of results.  
Two populations were studied, both including individuals with head injury that 
had been admitted to St. Olavs University Hospital. One population comprised all 
patients with severe head injury who had been treated at St. Olav Hospital from 
1998-2002. The next population comprised all patients who have been treated with 
moderate and severe head injuries at St. Olavs Hospital from October 2004 to July 
2009. From the latter population two samples were studied: first, a sample of 106 
individuals (5-65 years) who had been examined with MRI within four weeks post-
injury and second, a sample of 63 individuals (13-65 years) who had been tested with 
neuropsychological tests 3 months post injury. Control participants in the latter study 
were 48 healthy individuals, matched for gender, age and years of education. 
In the MRI studies, we found that all but one of the patients had visible, 
traumatic lesions in the brain parenchyma. It was common to find a combination of 
contusions and diffuse axonal injury (DAI).  DAI was very common, and was found 
in 90 % of patients with severe TBI and in 56 % of those with moderate injury. 
Patients with DAI had more severely disturbed consciousness as measured with the 
Glasgow Coma Scale (GCS) acutely after the accident. Only in patients with DAI, 
was the GCS score related to outcome. DAI was negatively related to outcome only 
when located in the brain stem. 
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 Brain stem injury was found in 46 % of patients with severe head injury, but 
also 14 % of the patients with moderate TBI.  
The individuals with TBI performed worse than healthy volunteers in most 
cognitive domains. We used the 5th percentile of the normative data as cut-off for 
impaired test score, and having  2 impaired test scores out of a selection of nine 
tests as definition of cognitive impairment. Doing so, we found that 43 % of the 
individuals with moderate TBI and 65 % of those with severe TBI had cognitive 
impairment. Cognitive impairment was associated with disability or complaints 
affecting daily life at 12 months post-injury. Yet, a substantial proportion of those 
with normal cognitive performance reported disability or complaints at the time of 
testing (69 %) or at 12 months follow-up (43 %). Thus, the sensitivity of the tests to a 
recent TBI or their ecological validity was rather low. 
Two thirds of the individuals who survived a severe head injury, and virtually all 
with moderate head injury, experienced a favourable outcome, that is either no, 
minor or moderate disability, and independency of others in daily activities. In the 
first population of severe TBI, however, only one third could participate in paid work 
or ordinary education more than three years after the injury. 
In both populations we found that approximately one third of those who survived 
severe TBI, experienced long lasting, severe disability, as measured with the 
extended Glasgow outcome scale. Severe disability was strongly predicted by 
bilateral brain stem injury on the MRI scan and being in a minimally conscious state 
or vegetative state 4 weeks post-injury, the latter also being a strong risk factor for 
epilepsy.  
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CHAPTER 1 GENERAL INTRODUCTION 
1.1 Incidence and mortality
The incidence of traumatic brain injury (TBI) differs among countries [19] as 
there are variations regarding frequency of traffic accidents, safety in work places 
and transportation, frequency of assaults and gun shots in the civilian society and, not 
least, participation in war with the increasing incidence of blast injuries [84]. 
Consequently, incidence figures from the US, as well as from some of the large 
developing countries, are of limited relevance to us in Norway. 
Tagliaferri et al. performed a meta-analysis on the incidence of TBI in Europe 
[150]. They derived an overall rate of hospitalized plus fatal TBI of 235 /100 000 pr 
year. Only some studies reported severity distribution, again with large variations, 
and thus the incidence of moderate and severe head injuries is not well known.  
When we started our data collection in 2004, Norwegian epidemiological 
research in the field of TBI had mainly been focusing on mild TBI, with the 
exception of a study of the epidemiology of hospital treated head injury from the 
northern Norwegian counties [66].  Concurrent with our studies, similar data have 
been published from other regions, and these are reviewed in section 5.1.5 of this 
thesis.  
 
Traumatic brain injury is the most common cause of death following trauma [39], 
which in turn is among the major causes of deaths among young people. For patients 
with severe head injury admitted alive to hospital, the mortality from the head injury 
is 25-40 %, depending on whether all age groups are included, and whether patients 
admitted alive, but with signs of herniation and no hope of survival are included. 
Mortality from TBI is probably decreasing. From the Traumatic Coma Data Bank, 
mortality after severe TBI (age 16-65) was 39 % in 1984-87, versus 27 % in 1988-96  
[87]. 
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1.2 Definitions and classifications of Head injury and Traumatic
brain injury 
1.2.1 Head injury and Traumatic Brain Injury 
The term Head Injury (HI) defines a trauma to the head, not necessarily the brain, 
although inevitably, that is the case with increasing severity of the HI. Thus, HI 
encompasses not only brain trauma, but also scalp lesions and cranial fractures, and 
the HI diagnosis may be used without evidence of loss of consciousness or altered 
brain function.  
A standard diagnosis of traumatic brain injury (TBI), used in the large cohort in 
the USA, Traumatic Brain Injury Model System (TBIMS, described in section 1.8.3) 
is: “external mechanical force causing damage to brain tissue as evidenced by loss of 
consciousness, post-traumatic amnesia, or objective neurological findings that can be 
reasonably attributed to TBI on physical or mental status examination, with or 
without skull fracture”. 
All the patients in our studies have clear evidence of mechanical forces acting 
upon the head as well as disrupted brain function in relation to the trauma, and the 
terms “Head injury” and “Traumatic brain injury” are both applicable.  
1.2.2 Mild, moderate and “definite” injury 
The WHO’s Task Force on Mild TBI (2004) identified inconsistency in the 
definition of Mild TBI across studies, typically regarding whether they included 
cases of Glasgow coma scale (GCS) score of 13 or not [21]. The Task Force 
recommended that a TBI was mild if GCS score was 13–15 after 30 minutes post-
injury, loss of consciousness lasted for less than 30 minutes and post-traumatic 
amnesia for less than 24 hours.  
However, there is a trend in the field of neurosurgery to classify patients with 
GCS score 13 as moderate head injury as the rate of complications and need for 
neurosurgical intervention is higher than when GCS score is 14-15 [104, 134].  
The term “definite TBI” has also been introduced as synonymously with the 
moderate-severe TBI spectrum. Some authors have proposed to include TBI cases 
with intracranial lesions detected by neuroimaging in definite TBI [88]. This would 
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represent a change in the most common criteria for mild TBI, since traditionally, 
pathology detected by neuroimaging has not been taken into account. However, there 
is a move towards developing also the patho-anatomical characteristics into new 
classification systems [149].  
1.3 Measurement of injury severity 
1.3.1 The Glasgow Coma Scale (GCS) 
This scale from 1974 was developed to assess depth of coma and impaired 
consciousness [152]. It is based on the observed response to stimuli regarding motor 
responses, verbal performance and eye opening. Although not primarily intended to 
be a system to grade head trauma severity, most TBI severity scales are based upon 
the GCS. The GCS scores range from 3 (no responses to painful stimuli) to 15 (fully 
alert and oriented patient). It has also been shown that in moderate and severe TBI 
the motor score alone may be used; with similar, or even better properties than the 
full scale [89, 153].  
1.3.2 The Head Injury Severity Scale (HISS) 
HISS is a two dimensional scale based on (a) injury severity assessed with the 
Glasgow Coma Scale Score (GCS) and (b) presence or absence of complications 
appropriate for the severity category [144]. The scale is widely adopted, and is used 
in the Scandinavian guidelines for management of HI. The scale defines cases with 
GCS score 13, or loss of consciousness (LOC)  5 minutes as moderate head injury. 
In order to comply with common terminology, we chose not to use the concept of 
“serious head injury” further subdivided into “severe; GCS score 5-8” or “critical; 
GCS score 3-4” in the HISS, but rather use the term “severe head injury “ or “severe 
TBI” for all patients with GCS score 3-8. 
1.4  Clinical phases during recovery
During recovery from TBI, several clinical phases with disturbed consciousness 
are recognized; from coma towards a fully alert and oriented state [114]. Typically, 
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each phase is longer than the preceding phase, and thus, recording duration of the 
clinical stages may provide professionals with valuable prognostic information.  
Fig 1.4.1. Traumatic Brain Injury - clinical phases during 
recovery
Coma Coma
(Vegetative state)
Minimally conscious Posttraumatic
state amnesia
Gradual improvement of cognitive functions
 
Figure 1.4.1 illustrates the clinical course of recovery of normal consciousness 
in TBI. The direct transition from coma to posttraumatic amnesia, depicted to the 
right, illustrates the less severe cases, where the vegetative state and the minimally 
conscious state may not be present as distinct clinical phases.  
1.4.1 Vegetative state 
The vegetative state (VS) is a mental state defined by absence of awareness 
about self or environment [79]. It is distinct from coma by presence of eye opening. 
Brain stem functions are usually preserved, and thus reflexes may be elicited that 
mimic responsive behaviour [7].  In the Glasgow outcome scale extended (GOSE), 
the GOSE score 2 is assigned to patients in VS. The diagnosis VS may be considered 
permanent 12 months after TBI [1]. Contrary to the belief of many laymen, and 
probably also some health professionals, permanent vegetative state appears to be an 
uncommon outcome after TBI [101].  
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1.4.2 The minimally conscious state  
A definition and diagnostic criteria for the minimally conscious state (MCS) 
were published by Giacino et al. in 2002 [52]. MCS is a disorder of consciousness, 
characterized by inconsistent, but clearly discernible, behavioural evidence of 
consciousness, and MCS can be distinguished from coma and VS by documenting 
the presence of specific behavioural features not found in either of these conditions. 
The MCS has an upper border to posttraumatic amnesia or a fully conscious state, 
and patients in MCS do not consistently show for instance ability to functional 
communication or functional use of objects. The concept of MCS has been widely 
adopted in the field of neurorehabilitation.  
1.4.3 Posttraumatic amnesia  
Posttraumatic amnesia (PTA) is commonly explained as the time period from the 
injury until the patient has regained day-to-day memory; however there is a now a 
trend towards emphasizing the component of disturbed consciousness and similarity 
with other delirious syndromes [148]. 
Before the GCS was available, PTA was used to indicate severity of injury. 
Russell et al., in the sixties, studied a large TBI population and classified injuries as 
“severe concussion” if PTA duration was between one and seven days and as “very 
severe concussion” when PTA lasted more than one week, and they did not 
distinguish PTA above that length [123]. More recent studies, however, have 
recognized that many patients with severe TBI have longer PTA and still experience 
a favourable outcome, and that further differentiation of PTA duration is useful [158]. 
PTA is a strong predictor of outcome, but it is challenging to measure PTA 
accurately. There are several assessment scales, constructed to cover different 
aspects of the PTA syndrome. Generally, scales measuring primarily the 
disorientation [68, 82], tend to produce shorter estimates of PTA duration than those 
measuring memory for items presented the previous day [151]. For practical reasons, 
it is generally accepted that the PTA duration should be estimated from the day of 
the injury, thus the given time also comprise the duration of coma, VS and MCS.  In 
several studies, cut off levels of PTA into weeks have been used, and this approach 
may be clinically useful. Taken together, PTA of less than one week has been 
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associated with high rate of good recovery [157] and better recovery of memory [17] 
and PTA duration of less than two weeks with less disability [157]. Presence of 
severe confusion at three weeks post-injury was associated with lower chances of 
return to productivity [137]. In a very recent study, the authors found four weeks 
post-injury to be a useful cut-off point, above which future moderate or severe 
disability is likely. Eight weeks of PTA was a clear cut-off above which good 
outcome was very unlikely and risk of severe disability increased [158]. 
1.5 Neuropathology and neurobiology of TBI 
Traumatic brain injury (TBI) is characterized by a complex pathology. The 
primary lesions comprise focal / multifocal injury; haematomas and contusions and 
diffuse brain injury; axonal as well as neuronal and vascular [15]. At the microscopic 
level, a cascade of cellular processes take place within the brain parenchyma [114], 
and our understanding of these is constantly reviewed. Advances within the field of 
pathobiology of TBI include increased understanding of exitotoxicity, mitochondrial 
dysfunction and inflammation following TBI [73, 95], the complex functions of the 
glial cells [143], biomarkers [69], the microstructure and function of injured axons 
and patterns of cell death after diffuse brain injury [20, 44].  
1.5.1 TBI and localization in the brain 
Surface contusions are most severe in the frontal and temporal lobes due to the 
irregular bony surfaces of the anterior and the middle cranial fossa [15]. Diffuse 
axonal injury is typically seen in the gray-white matter junction of lobar white 
matter; most commonly in the frontal and temporal lobes, in the corpus callosum; 
typically in the splenium due to the close relation to the falx, and in the brainstem; 
the dorsolateral part of the midbrain and upper pons [48, 51, 109]. 
1.5.2 Diffuse axonal injury – neuropathology and experimental studies 
Diffuse axonal injury (DAI) is an important constituent of the white matter 
pathology in TBI, and has been related to high energy traumas, as motor vehicle 
accidents. DAI is more extensive and more severe following severe TBI, but occurs 
across a larger spectrum of injury, and has also been detected in mild TBI [16]. The 
 
 
  
 
23
concept of DAI has its origin from the field of neuropathology and experimental 
research with mechanical models and animal models. And also today, a direct 
observation of damaged axons is only possible through the microscope, although 
imaging methods for depicting the integrity of the nervous tissue are continuously 
improved. In experimental research, the term traumatic axonal injury (TAI) is 
preferred, but in general DAI and TAI seems to be used synonymously in the 
medical literature. 
As early as 1943, Holbourn showed by use of a gelatine  model of the brain, that 
structural deformations could induce injury to the brain and he also postulated major 
types of forces that could produce this deformation [62]. The importance of these 
observations were later recognized by Strich, who published the first pathologic 
descriptions of the shear injuries of the white matter in humans [147]. Later, 
Gennarelli et al. subjected primates to angular acceleration of the head. They found 
that three grades of DAI could be produced, with severity of DAI depending on the 
magnitude and duration of the acceleration and the direction of head motion [47]. In 
this model the DAI was similar to findings in man. Concurrently, comprehensive 
neuropathological research was undertaken, by Adams and Gennarelli et al. who 
performed autopsy of 635 TBI cases from 1968-1982 [3], and they proposed the 
following grading of DAI:  
Grade 1: evidence of diffuse axonal damage in the white matter of the 
hemispheres including the corpus callosum, in the brain stem and occasionally in the 
cerebellum: this damage can only be identified microscopically. 
Grade 2: A focal lesion was identified in the corpus callosum in addition to the 
diffuse damage described above, and in some cases this was also only identified 
microscopically. 
Grade 3: A focal lesion was found in the dorso-lateral quadrant of the rostral 
brain stem in addition to the diffuse damage, and in many cases one of the focal 
lesions could only be identified microscopically. 
(Grades 2 and 3 were said to be severe if they were apparent macroscopically.) 
 
Since this work of Adams and Gennarelli, a lot of research has been conducted to 
investigate the effects of axonal injury at the microscopic level. The experimental 
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research conducted by Povlishock’s group has demonstrated that the suggestion by 
Strich and Adams of a mechanical transsection of the axon resulting in axonal 
retraction and formation of axonal bulbs (primary axotomy) for a large part was not 
correct. Rather, the forces of injury diffusely alter segments of the axons regarding 
membrane permeability and axonal transport, but not uniformly. Thus, different 
populations of axons may respond in different fashions to injury. Especially in axons 
sustaining long duration of altered axolemmal permeability, a delayed process occurs, 
eventually leading to axonal failure and disconnection (secondary axotomy) [44]. 
Moreover, and contrary to earlier belief, axonal injury has also been demonstrated in 
unmyelinated fibres [118]. Even though the diffuse axonal injury is often followed 
by degeneration, it has also been demonstrated that not all axonal injury progress to 
cell death [43]. Furthermore, the mechanisms of diffuse cell death are complex, and 
not restricted to axotomy-related changes [44]. Taken together, following TBI, there 
are concurrent detrimental processes, scattered in the brain, targeting axons, neuronal 
cell bodies and also microvasculature. Thus, the concept “diffuse traumatic brain 
injury” probably covers this complexity better. 
1.5.3 Brain stem injury 
Brain stem injury associated with head injury can be characterized as primary; 
directly caused by the forces of the trauma, or secondary; resulting from the ischemia 
associated with herniation of the brain. The latter has been the most common type in 
autopsy studies, but also primary injuries have been demonstrated [98, 139]. Primary 
brain stem lesions comprise DAI, haemorrhage, contusions and lacerations [15]. The 
primary brain stem haemorrhages may be seen in the context of a lethal form of 
diffuse brain injury. Brain stem contusions may be associated with basal skull 
fractures or result from the impact against the free edge of the tentorium [125]. 
1.6 Computed Tomography in TBI 
1.6.1 Classifications for research 
The Marshall classification from 1991 was based on experiences from the 
Trauma Coma Data Bank and has been extensively used for prediction of outcome 
 
 
  
 
25
[92] (Appendix 1).  The Rotterdam classification was later developed as it could be 
shown that not only the radiological features covered by the Marshall Classification, 
but also other characteristics of the computed tomography (CT) scan were 
independently predictive of outcome [102] (Appendix 2). The most important 
components of the scales are mass lesions exceeding a certain volume, signs of 
raised intracranial pressure, such as size of the basal cisterns and presence of midline 
shift, and (in the Rotterdam classification) traumatic subarachnoid haemorrhage. For 
both scales, adequate inter-observer reliability was recently demonstrated, for 
neuroradiologists as well as for neurosurgeons [27]. It has recently been 
recommended that the worst CT scan should be subjected to classification [133]. 
1.6.2 The prognostic value of CT 
The prognostic value of CT has been shown in many studies. Studies of CT and 
outcome have the advantage of being large [103] as CT is performed in the 
diagnostic setting in all cases. CT is probably most predictive in patients with severe 
injury, when life threatening hematomas or severe signs of increasing ICP are 
depicted [105]. 
1.7 Magnetic resonance imaging in TBI 
The use of magnetic resonance imaging (MRI) was reported in head trauma 
patients early in the eighties, but especially after 1986, several important studies 
were conducted. It has consistently been demonstrated that MRI is more sensitive 
than CT in detection of parenchymal lesions; DAI, brain stem lesions and cortical 
contusions [50, 74, 169]. Gentry et al. studied the characteristics and distribution of 
traumatic lesions in a series of patients with TBI, and also compared these with 
autopsy findings [49]. They demonstrated that the patterns of lesions depicted in the 
white matter with MRI were identical to what was found in the pathologic and 
animal studies [49] and this has been the rationale for use of a modification of the 
grading of DAI of Adams et al. in MRI studies. 
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1.7.1 The clinical scan protocol for head injury 
The first studies of MRI in TBI were performed with low field strength and few 
sequences. Today, a typical MRI scan protocol in head trauma is performed at a 
system with field strength of 1.5 or 3 Tesla, and in addition to T1 and T2, consists of 
a T2*-weighted gradient echo sequence, a fluid-attenuated inversion recovery 
(FLAIR) sequence and diffusion-weighted imaging (DWI). 
T2*-weighted gradient echo MRI was introduced as early as in 1986 [40]. The 
technique utilizes the paramagnetic properties of the degradation products of 
haemoglobin which induce a focal signal loss. Thus, this technique is sensitive for 
the detection of cerebral micro-haemorrhages which appear dark on the scan (Fig 
1.7.1). T2* is a sensitive method in diagnosing the micro-haemorrhages believed to 
be associated with DAI [128] . Even higher sensitivity is found for examinations 
performed at 3 Tesla since the focal signal loss from haemoglobin degradation 
products increases with higher magnetic field strength. [127]. Studies have found 
increased load of microbleeds in patients with more severe injury [155], but the 
clinical significance of the load of traumatic microbleeds or the spatial distribution is 
not yet clear [111].  
Fig 1.7.1. 
Transversal T2*-weighted gradient 
echo image. Arrow shows micro-
haemorrhages in the frontal lobe white 
matter indicating DAI. 
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FLAIR is an MR imaging sequence that was introduced in 1992 [34], and 
reported used in head injury in 1997 [10, 34]  It is a T2-weighted sequence where the 
high T2-signal from the cerebral spinal fluid is suppressed, while the signal from 
traumatic brain oedema or gliosis remains bright, thus increasing the depictability of 
tissue injury. The lesions typically appear as white matter hyper-intensities (Fig 
1.7.2). In the acute stage, FLAIR sequences are used for the detection of oedema in 
the white matter, thought to reflect DAI [10, 109], whereas in the chronic stage, the 
hyper-intensities probably represent gliotic scarring secondary to the traumatic brain 
injury [110]. The volume and number of FLAIR lesions have been related to 
outcome [22, 91]. The oedema, and thus the hyper-intensities depicted acutely, 
however, gradually vanishes with time, and thus quantification of lesion volume will 
depend on the time passed since injury. 
 
Fig 1.7.2 
Sagittal FLAIR image. 
Arrow shows lesion in the 
corpus callosum, indicating 
DAI. 
Diffusion-weighted imaging was developed in 1986 and was first reported in 
human TBI in 1999 [85]. The method is based on adding strong and rapid magnetic 
field diffusion sensitizing gradients to a fast T2-weighted imaging sequence. This 
technique provides image contrast, which results from the molecular diffusion of 
water molecules in the brain tissue [126]. Since the DWI contains both diffusion and 
T2- information, these images are compared to the apparent diffusion coefficient 
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(ADC) map which is a parametric image where the T2-effects have been eliminated 
while the diffusion effects remain. DWI can reliably distinguish between vasogenic 
oedema (elevated diffusion) and cytotoxic oedema (restricted diffusion). ADC values 
in certain regions of interest can also be quantified, which is a common design in 
research. Using ADC maps, it was demonstrated that ADC values were lower in 
normal appearing areas of the brain in individuals with TBI compared with controls. 
Furthermore a correlation with outcome was found [63].
1.7.2 Advanced methods 
Several methods require post-processing of MRI data. Examples are MR 
spectroscopy, different methods for measurement of brain volumes, functional 
magnetic imaging (fMRI) and diffusion tensor imaging (DTI). Since DTI is 
increasingly used in MRI research, and is proposed to be a sensitive biomarker of 
DAI, this method will be briefly described. 
In nerve fibres, diffusivity is greater in the direction of the axon, than 
perpendicular to the fibres (diffusion anisotropy). Diffusion tensor imaging (DTI) is 
based on sampling of diffusion weighted images for many directions, and 
computation of eigen-values for the three dimensions [80]. Then, within a voxel, 
diffusion anisotropy indices may be computed, like FA (fractional anisotropy) values. 
Processes that damage the microstructure of the axon (like TBI) may result in 
decreased axial diffusivity and lower FA value.  
From the DTI data it is also possible to distract parameters for so-called fibre 
tracking, thus gaining information of in-vivo orientation of the tissue in space.  
DTI is increasingly used in TBI research, and may depict axonal damage beyond 
that of conventional MRI [168]. It has been used in mild TBI [106, 124] where 
reduced FA values have been demonstrated in several areas compared with controls 
and also a correlation between abnormal regions and cognitive performance was 
found [106]. DTI has been used in patients with very severe injury, where DTI 
parameters were studied longitudinally and a higher tendency towards normalization 
was found in the patients who recovered function [140]. 
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1.7.3 Brain stem injury  
The earliest reports based on MRI of the occurence of brain stem lesions, are 
from Gentry et al. in the late eighties [51]. They compared CT and MRI in the 
detection and characterization of brain stem lesions and also investigated the 
frequency, location, distribution and the differentiating features of primary and 
secondary brain stem lesions. Later, Firsching et al. performed very early MRI in a 
large series of patients with severe injuries. They found a very high incidence of 
brain stem injury, 64%. Patients with bilateral pontine lesions had a 100 % mortality 
rate as opposed to patients without brain stem lesion; with 9% mortality [45]. In 
general lesions in pons and mesencephalon have been associated with poor prognosis, 
most notably when they are bilateral and symmetrical [45, 161]. 
Also with MRI, two patterns of brain stem lesions have been found. Patients with 
superficial, focal brain stem injury caused by the impact against the free tentorial 
edge, had a better prognosis than those with a deeper axonal injury in the dorsal brain 
stem [138]. 
1.7.4 Remaining questions
Much of the recent research regarding MRI in patients with TBI, has been 
performed in selected patients, and has focused on the development of more sensitive 
techniques as well as on investigation of mechanisms. Also correlations between 
findings and outcome have been studied.  Some important contributions were 
described above in the section 1.7.1.  
Still, studies of high external validity that are informative to clinicians regarding 
the clinical usefulness of MRI in TBI are few. Since the studies of Gentry et al, MRI 
characteristics have not been much studied in series of consecutive head injury 
patients. Particularly, more MRI studies of patients with moderate head injuries are 
needed. Firsching et al. studied a cohort of patients with very severe injuries, as did 
Kampfl et al. [72]. Lagares et al. studied consecutive patients with moderate to 
severe TBI, yet they did not report how patients were selected to MRI  [76]. Some 
studies, like those of Gentry and Kampfl, were also performed before the 
introduction of the most sensitive MRI sequences that are now common in clinical 
protocols. 
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For example it is argued that DAI may be a common cause of poor outcome [104, 
160] and that this type of injury is likely to be responsible for many of the cognitive 
deficits resulting from moderate to severe TBI [129]. However, we have not found 
any MRI studies that actually compared outcome in patients with and without DAI. 
And with the current understanding that DAI may be a component of all TBI from 
the mild injuries to the fatal cases, apparently the presence of DAI, as such, can not 
be regarded a general marker of poor prognosis. Thus, the sensitivity and relevance 
of the MRI based diagnosis of DAI still needs to be investigated. 
Furthermore, the prognostic value of MRI for the clinicians is not well 
established [160], and few have studied the value of MRI in addition to established 
prognostic factors, such as age, injury severity, pupillary reactivity and CT 
characteristics in multivariable analyses [99]. 
1.8 Outcome and prognostic factors in TBI 
Moderate and severe TBI have adverse effect on cognitive [36] and social [154] 
functioning, and is also associated with psychiatric [59] and neurological disorders 
[12]. The wide array of studies makes it an impossible task to summarize current 
knowledge of outcome after TBI within the context of this thesis. Still, it is a fact that 
it is difficult to compare findings across studies, since few have similar datasets 
when it comes to patient selections, outcome measures and time to follow-up. 
Moreover, there are large differences between countries regarding social conditions; 
access to health care and social benefits and general employment rate, and these 
further complicate comparisons. Finally, reviews have identified a high frequency of 
studies with significant methodological weaknesses [54, 135, 136]. After a consensus 
conference in USA in 1998, it was stated, that “mild, moderate and severe traumatic 
brain injury (TBI) differ greatly in symptoms, signs, recovery and outcomes, and that 
each category needed to be studied specifically” [115]. Nevertheless, when research 
since this conference was reviewed in a paper in 2006, one of the conclusions was 
that ”the natural history of mild, moderate and severe TBI has still not been 
adequately investigated” [116].  
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Thus, there is still a need for updated studies of outcome, from different 
countries and different settings, to inform clinicians about what clinical course and 
outcomes to expect. In the following, some types of studies and research questions 
are briefly described. 
1.8.1 The large databases of neurosurgical patients 
There are some very large meta studies of patients recruited from a neurosurgical 
setting. These studies have typically investigated global outcome, measured with the 
Glasgow Outcome Scale (GOS), which is described in section 3.5.1. Follow-up has 
mostly been limited to the first 6 or 12 months post-injury [25, 65, 93, 99, 100, 120, 
122]. One of the largest and most recent is the IMPACT database (International 
Mission for Prognosis and Clinical Trial design database), which utilized data from 
8686 patients drawn from eight randomized controlled trials and three observational 
studies. The majority of the patients included had severe TBI, but some studies 
included up to a 28 % moderate cases [90]. The most powerful independent 
prognostic variables were age, GCS motor score, pupil response, CT characteristics, 
hypotension, hypoxia and abnormalities of glucose [99]. Given the excellent power 
of these studies, the major prognostic factors are now well established regarding 
death and disability, at least for severe disability, at 6 months post-injury.  
1.8.2 Long-term outcome in neurosurgical cohorts
Surprisingly few studies have described long-term outcome in neurosurgical 
samples of survivors of severe head injuries. It may be too early to assess the true 
consequences of  head injury after six months, especially in samples with severe 
injuries, where recovery tend to be slower and functional gains have been shown to 
occur even after the first year [32, 108].  In these studies, outcomes assessed are 
more varied; disability [61], return to work [33], cognitive functioning [37], 
psychological distress [35] and quality of life [37]. Unfortunately, these are often 
flawed by loss to follow-up of 30-50 %. As there are differences between 
participants and non-participants [30], this may have biased the results. Long term 
outcome after head injury was explored in a cohort from Glasgow; they found 
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disability in 76 % of the survivors of severe TBI; 36 % experienced severe disability  
[162]. 
1.8.3 Long-term outcome in cohorts of rehabilitation patients 
In the US, the TBI Model System is a large dataset of more than 8000 TBI 
patients who have been admitted to a trauma center and subsequently received in-
patient rehabilitation in one of the connected rehabilitation centres 
(http://www.tbindsc.org). The centres are of high quality, and professionals are 
obliged to carry out comprehensive data collection according to the study protocol. 
Each center also focuses specifically on selected research topics. This database 
contains longitudinal data up to 15 years post-injury, and has resulted in numerous 
well designed studies. However, as the included patients needed inpatient 
rehabilitation, this cohort consists of a more severely injured sample [31].  
Many other cohorts and studies could be mentioned specifically. However, a 
systematic review on prognostic factors for long-term disability and productivity was 
published a few years ago [163]. Taken together, predictive of disability were older 
age, pre-injury substance abuse and more severe disability in the subacute phase. 
Wood reviewed really long-term outcome in 2008 [167], and found that functional 
abilities may improve over years, and the importance of initial injury severity as 
prognostic factor weakens over years. For late outcome, it was summarized that 
neuropsychological impairment, low pre-morbid education, lack of insight and 
coping style were negative predictors of outcomes.  
1.8.4 Returning to work or school 
Returning to work or school (productivity) is an important goal for individuals 
following head injury and is associated with higher quality of life, mental and 
physical health and social integration [6, 107]. Yet, participation in competitive work 
is low after severe TBI, also among those who were previously employed [18, 29, 
113, 122]. Non-productivity has been associated with pre-injury unemployment, 
longer PTA duration, substance abuse and higher disability by admittance to 
rehabilitation [163]. There is also strong evidence that restrictions in working life are 
directly related to cognitive impairments in the early stage [11, 135]. It has been 
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shown that part-time work after TBI was related to higher social integration and 
engagement in home activities than full time work [107], which is not surprising 
given the reduced cognitive capacity and fatigue that is common after TBI [141]. 
Supported employment was cost-effective for individuals with TBI if carried out 
over time, and with structured support [159].  
1.8.5 Outcome in patients with very severe injuries 
In recent years, more attention has been paid to rehabilitation interventions and 
outcomes in the group of patients with the very severe head injuries. These patients 
show heterogeneity of outcome, with some individuals eventually experiencing a 
favourable outcome [53, 57, 77]. Consequently, the field of brain injury 
rehabilitation in Norway has developed more structured rehabilitation services for 
this group during the last years. This has, among other factors, been inspired by the 
Danish approach with centralization of early, intensive rehabilitation after very 
severe brain injury  [41].  
1.8.6 Posttraumatic epilepsy 
Posttraumatic epilepsy (PTE) may be divided into early and late. Early seizures; 
that occur during the acute phase (often defined as within 1 week), are often 
interpreted as symptomatic. Late seizures imply high risk of new seizures, and 
antiepileptic drugs are usually initiated after just one seizure. 
Findings from previous studies have shown that individuals suffering penetrating 
injury, injuries with certain radiological characteristics and severe head injury are at 
higher risk [9, 42, 46, 96]. There are, however, no studies exploring the risk and risk 
factors within samples of severe TBI.  
1.9 Cognitive deficits and neuropsychological assessment 
Cognitive dysfunction is very common after moderate and severe TBI [36]. 
Particularly vulnerable are information processing speed and attention [94, 164], 
memory [156] and executive functioning [38]. This is in line with the pathobiology 
of TBI described in section 1.5.1., as the frontal and temporal lobes are predilection 
sites of the diffuse axonal injury as well as contusions, and as the diffuse axonal 
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injury would reduce the efficacy of the networks within the brain. There is a dose-
response relationship between injury severity and cognitive dysfunction [130, 141], 
and deficits are more pronounced early after the injury. Several studies have reported 
time course of recovery, and steepest recovery curves are seen for the first few 
months. Furthermore, recovery curves were not identical for the different cognitive 
domains [26]. It has been shown that cognitive impairments mediate the reduction in 
function commonly seen after TBI [117], and assessment of cognitive functioning 
with neuropsychological tests is an important part of the diagnostic of individuals 
with TBI. However, the traditional neuropsychological tests have been criticized for 
having low ecological validity [24],  and the interpretation of the test results is also 
challenged by the fact that healthy individuals perform below the normal range in 
some percentage of administered tests [67, 131].  
 It is common to perform the first neuropsychological assessment during the first 
months after the injury, but after resolution of PTA [135].  
1.9.1 Normative data and definition of impairment 
Neuropsychological test results are typically given as raw scores, and also 
converted to standardized scores. A standardized score is a measure of the raw score 
compared with the mean of a reference sample, usually one that has been published 
by the manufacturer of the test. The reference sample usually comprises healthy 
individuals in the same age group, or a group matched on age and education. 
Standardized scores may be given as different units: Standard scores (S-scores) with 
mean of 10 and a standard deviation (SD) of 3, T-scores with a mean of 50 and a SD 
of 10, Z-scores with a mean of 0 and a SD of 1.0 or percentiles, given as the 
percentage of the reference sample performing as low or lower on the test, the mean 
being 50, and 1 SD corresponds to the 16th percentile.  
An individual’s standardized test score is often classified as impaired if it is 
below 1.5 SD according to the reference norms for the test (T-score  34, S-score  
5; Z-score  -1.5 or percentile  5). This is rather common practice in 
neuropsychology, but other cut-off points may also be applied. In the clinical context, 
before concluding that a low test score reflects impairment, it is also evaluated in the 
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light of general abilities and performance on other tests [146], but the empirical basis 
for this subjective evaluation is currently debated [67].   
1.9.2 Effect sizes 
During the last years, there has been a shift towards requesting researchers to 
present a measure of the magnitude of effects (effect size), not just the p-value 
indicating statistical significance. One frequently used measure in neuropsychology 
is a standardized difference of means, often computed as the Cohen’s d:  
 
Cohen assumed equal variance and normal distribution, and did not give details 
of how s (= SD) should be applied in unequal samples. Many uses pooled SD if 
groups are unequal (spooled), and this is computed by the following formula: 
 
 
 
Cohen denoted d = 0.8 as large, d=0.5 as medium and d=0.2 as small [28]. 
Other similar measures exist, like the Glass’  or d, using only the SD of one 
group, typically the control group: 
 
When data are not normally distributed, an estimate of effect size may be 
computed by dividing the difference between the median scores by the Inter quartile 
range (IQR) x 0.75 [56].  
The effect size is directly related to power and sample size; if the standardized 
difference between two groups is small, the sample needs to be very large to have 
sufficient power to detect a true effect. This was studied by Cohen in 1962, where he 
demonstrated that the majority of studies had low chances to prove true effects due to 
low power. A later review has shown that this concern is still relevant in 
neuropsychology [14]. 
The size of d may also be thought about in terms of overlap between two 
distributions (Fig 1.9.1).  
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Figure 1.9.1. Overlap of populations as a function of effect size. 
A: d=0.8 (large); 21 % of the lower population exceeds the mean of the higher. B: 
d=0.2 (small), C: d=4.0  
(From “Introductory Statistics for the Behavioral Sciences”; Welkowitz, Cohen and 
Ewen; 2006; reprinted with permission from Wileys and Sons). 
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CHAPTER 2  AIMS OF THE THESIS 
2.1 Paper I: 
To describe long-term outcomes in a consecutive sample of patients admitted 
with severe head injury to our hospital in the five-year period from 1998 to 2002. 
The hospital is the only trauma centre serving a defined Norwegian health region, 
and thus, the study had the potential to provide some population-based estimates. 
Furthermore, we wanted to relate the outcomes to injury severity.  
2.2 Paper II: 
To describe the frequency and staging of DAI depicted with early MRI in 
consecutive patients with moderate and severe head injury admitted to a 
neurosurgical department from October 2004 to august 2008. Furthermore, we 
wanted to relate the findings to the Glasgow Coma Scale score and to global patient 
outcome. 
2.3 Paper III: 
In the same cohort of patients with moderate and severe head injury as described 
in paper II, we further sought to describe the depth distribution of primary traumatic 
lesions, describe the prevalence and outcome of different types of brainstem injury 
(BSI) and explore the possible prognostic value of early MRI scans. 
2.4 Paper IV: 
To explore the magnitude and frequency cognitive impairments three months 
after moderate and severe traumatic brain injury (TBI) and study the relation to 
presence of complaints or disability at one year follow-up. 
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CHAPTER 3  MATERIALS AND METHODS 
3.1 Setting
3.1.1 The Health region of Central Norway and St. Olavs Hospital 
Norway is divided into four health regional authorities, and patients who were 
included in the studies described in this thesis, mostly live in Central Norway. The 
region has three counties (Møre og Romsdal, Sør-Trøndelag and Nord-Trøndelag) 
and serves around 666 000 inhabitants.  
St. Olavs Hospital is the regional university hospital and is situated in the city 
Trondheim, Sør-Trøndelag County. The studies in this thesis comprise only patients 
treated in this hospital. The hospital is the local hospital of the county; with 287 000 
inhabitants, and the only level I trauma centre in the region. Furthermore, it is the 
only hospital in the region with neurosurgical service. Thus, the patients admitted 
with severe head injury came from the whole region. Regarding moderate head 
injuries in patients younger than 65 years, 50 % of the patients were inhabitants of 
Sør-Trøndelag County. The remaining 50 % lived outside the county, and thus 
belonged to other local hospitals, but were admitted to St. Olavs Hospital due to 
either location of the accident, or because observation in a neurosurgical unit was 
indicated.  
3.2 Study design and study populations 
3.2.1 Study population 1998-2002 
The study in Paper I is an observational study that can be described as a 
prospective follow-up study, but where the participants and the injury-related 
variables were collected retrospectively. In this study we aimed at tracking all 
patients who had been treated with severe head injury at St. Olavs University 
Hospital during 1998-2002 for evaluation of long-term outcome. Figure 3.2.1 
describes the study sample.  
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Figure 3.2.1. Study population 1998-2002 
 
All patients treated with severe 
head injury during 1998-2002 
n= 135 
Patients invited for outcome 
assessment  
n= 94 
Death due to the head injury first 6 months
n= 32            
Death 6 – 36 months post-injury; all causes   
n= 8 
Did not consent;
n= 1
Lost to Follow-up
n= 0
PATIENTS EVALUATED FOR LONG-TERM OUTCOME 
n= 93
All patients admitted alive with 
severe head injury during 1998-
2002
n= 146 
Death due to other cause first 6 months 
n= 1
Death of other injuries first 24 hours 
n= 2          
No treatment initiated due to irreversible 
intracranial hypertension 
n= 9
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3.2.2 The Head Injury Project– running since 2004 
The Head Injury Project is an on-going cohort study where all patients admitted 
with moderate and severe head injuries at St. Olavs University Hospital, are 
consecutively registered. The cohort study was started in October 2004. By the time 
the last participant in the studies (Paper IV) was included, in July 2009, 290 patients 
had been registered. There are no exclusion criteria. The cohort study is run in 
collaboration between several departments at the hospital: Department of 
Anaesthesia and Acute Medicine, Department of Neurosurgery, Department of 
Diagnostic Imaging and Department of Physical Medicine and Rehabilitation. The 
data collection is comprehensive and research topics are numerous within pre-
hospital management, intensive care medicine, neurosurgery, neuroimaging, 
rehabilitation and outcome. 
Up until July 2009, only 8 persons had not consented for follow-up, Thus, the 
participation rate is 97 %. Of those who have consented, only 3 (1 %) have been lost 
to follow-up.  
The groups of individuals with TBI studied in Paper II-IV are all participants in 
this main cohort. 
3.2.3 The study sample in the MRI studies 
The sample of patients in Paper II and III, encompass patients aged 5-65, where 
MRI was performed within 4 weeks post-injury. The selection of patients is 
described in Figure 3.2.2.  
3.2.4 The study sample in the neuropsychology study 
The sample of patients in Paper IV, were patients aged 13-65, who had been 
assessed with a standardized neuropsychological test battery three months post-injury. 
The selection of patients is described in Figure 3.2.3. 
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Figure 3.2.2. Selection of patients for the MRI studies
 
Patients who were examined within 4 
weeks
n= 108 
Premorbid brain injuries; n= 11 
Refused MRI examination; n= 3 
Non-head injury death < 6 months 
n= 1 
Patients included in Paper II and III
n= 106 
Medical contraindications; n= 10 
All patients 5-65 years who survived 
the acute phase
n= 159 
Logistical reasons;  n= 27 
Selection for 
early MRI 
 
Poor image quality; n= 2 
PATIENTS WITH FOLLOW-UP DATA 
n= 105 
Death due to the head injury acute 
phase;  n= 21
All consenting patients 5-65 years 
admitted with moderate and severe 
head injury between October 2004 
and August 2008  
n= 182 
Death of other injuries during acute 
phase; n=2
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Figure 3.2.3. Selection of patients for the neuropsychology study
Refused of logistical reasons; n= 9 
Refused examination; n= 7 
Patients included in Paper IV 
n= 54 
Premorbid condition; n = 17 All patients 13-65 years who 
survived > 3 months 
n= 104 
Unable to cooperate; n= 14 
Not Norwegian speakers; n= 2 
PATIENTS IN THE NEUROPSYCHOLOGY SAMPLE 
n= 63 
Death due to the head injury < 3 
months; n= 15 
 
Patients 13-65 years eligible for 
neuropsychological testing 
 
 
n= 73 
Convenience patients included in 2008 
and 2009   
n= 9 
Lost to follow-up;  n= 1 
Death due to other injuries, acute 
phase; n=1 All consenting patients aged 13-65 
admitted with moderate and 
severe head injury between 
October 2004 and October 2007 
n= 120 
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3.2.5 The control group 
The control group was established from 2008 to 2009. It consisted of 48 persons 
and was matched with the patient group on the factors age, sex and years of 
education. One test technician and two master level students (psychology and 
neuroscience) performed the testing of control participants.  
3.3 Procedures for inclusion and data collection
3.3.1 In the study of the patients from 1998-2002 
The last author of the papers identified patients who had been consecutively 
admitted with severe head injury during the specified time period. Lists of 
hospitalized patients, with relevant diagnostic codes were checked for eligible 
patients and followed by review of the medical records to select patients with severe 
head injury. Medical records and CT scans were reviewed to collect the injury 
related variables of interest. Prior to the follow-up interviews, written information 
about the study was sent by mail. Next, they or their relatives were contacted by 
telephone, and then oral consent was obtained. Four patients had died more than 
three years post injury. In these cases we wrote to their relatives and asked for their 
consent to provide the information necessary to assign the patient to an outcome 
category based on their function prior to the disease that caused death.  
3.3.2 In the Head Injury Project 
Residents and research assistants at the neurosurgical department identified 
patients admitted with moderate or severe head injury, and patients or relatives were 
provided written information about the study. Demographic variables were obtained 
through contact with the families. Injury related variables were collected by the 
resident who first examined the patient at admittance, by completing a form designed 
to record the specified variables of interest. The residents had access to discuss 
inclusion criteria and case variables with experienced physicians in charge of the 
database. The data collection form is comprehensive and encompasses variables 
documenting demographic data, mechanism of injury, pre-hospital management and 
transportation times, variables describing physiological and cerebral state at several 
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time points as well as treatment and procedures applied in the different stages of the 
hospital stay. The variables relevant for this thesis are displayed in tables in the 
separate papers. Procedures regarding neuroimaging, outcome assessment and 
neuropsychological assessment are described in separate sections. 
3.3.3 Duration of PTA 
Duration of PTA, which was used in Paper IV, as well as the clinical condition at 
4 weeks post-injury, used in Paper I, were estimates made by the author of this thesis. 
This was performed as a clinical judgement of the whether the observed or described 
behaviour was best described as (a) an oriented state; the patient being cooperative 
and oriented to place and situation, (b) posttraumatic confusion (PTA), (c) the 
minimally conscious state or (d) the vegetative state. For definitions, see section 
1.4.3. 
3.4 Neuroimaging
3.4.1 Computed Tomography
The CT variables in the study were derived from the CT examinations which 
were routinely performed as part of the clinical management. In the study described 
in Paper I, the CT scans were reviewed and classified according to the Marshall CT 
Classification [92] by a trained neurosurgeon.  
In the study described in Paper II and III, the scans were all reviewed by a 
radiologist who participated in this study in order to classify findings according to 
the Marshall CT Classification and the more recently proposed Rotterdam CT 
Classification. See also section 1.6.1. 
 
3.4.2 Magnetic Resonance Imaging  
MRI was performed at 1.5 Tesla, by use of a protocol which included T1- and 
T2- weighted imaging, T2-weighted FLAIR imaging, T2*-weighted gradient echo 
imaging and diffusion weighted imaging, for description see also 1.7.1. A detailed 
description of the parameters of the scan protocol is given in Paper II.  
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MRI examinations were reported by two neuroradiologists. Later they, as well as 
the author of this thesis, reviewed the scans to obtain the following variables: DAI 
was graded 1-3 as described in Paper II, contusions were classified as uni- or 
bilateral and as 1 versus  2, brain stem lesions were classified as contusions or DAI; 
uni- or bilateral and depth of deepest lesion depicted as shown in the table below. 
 
MRI derived depth of lesion
Level 
 
Definition 
Hemispheres Traumatic lesions1 confined to the cerebral cortex or 
lobar white matter  
Central 
 
Traumatic lesions1 in the corpus callosum, thalami or 
basal ganglia2 
Brainstem, 
Unilateral 
 
Traumatic lesions1 in the brain stem unilaterally2 
Brainstem, 
Bilateral 
 
Traumatic lesions1 in the brain stem, bilaterally2 
1Signal loss compatible with micro-bleeds (in the GRE sequence) or increased 
signal intensity compatible with tissue edema (in the FLAIR sequences). 
2 Traumatic lesions at a higher level may also be present. 
 
We further made a distinction between two types of primary lesions in the brain 
stem. The primary were (a) brain stem contusions; these were superficial lesions, 
typically situated anteriorly, and hypothesized to result from the brain hitting the free 
tentorial edge and (b) DAI lesions; involving deeper parts of the brain stem, and 
these could be unilateral or bilateral. MR images of the two types of brain stem 
lesions are presented in paper III.  
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3.4.3 Inter-rater reliability 
For evaluation of reliability of the classification of MRI lesions used in Paper II 
and III, 31 cases were drawn evenly and blindedly from the ascending list of patients. 
Their scans were scored by a third neuroradiologist who was blinded to clinical 
information and previous classification. Lesions were classified according to 
presence and staging of DAI, presence and type of brain stem lesions, and presence 
of lesions in deep gray matter.  
3.5 Outcome measures 
3.5.1 Glasgow Outcome Scale Extended  
For global outcome, the Glasgow Outcome Scale Extended (GOSE) was used, 
which is an extended version of the widely used Glasgow Outcome Scale (GOS) [70, 
71, 165]. The scales have been shown to have good discriminating abilities and low 
ceiling effect [64] and may also be used by telephone [112]. In the papers I-III, the 
term disability was used to cover severe and moderate disability defined as 
categories in the GOSE, and disability encompasses the outcome categories GOSE 2-
6 (In GOS the corresponding categories would be GOS 2-4) (Appendix 3). In GOSE 
7 and 8, symptoms caused by the injury may be present, and if to a degree that 
affects daily life, this may be denoted as “minor disability” (GOSE 7) [165]. In Paper 
IV, we dichotomized the GOSE score between 7 and 8, to study the occurrence of 
what we described as “complaints or disability”, that is a GOSE score  7.  
Outcome was assessed using the structured interview for GOSE [70, 71, 165] by 
telephone (Paper I), personal contact (Paper IV) or either of the two (Paper II and III). 
In order to reduce the potential error associated with the telephone setting [81], 
relatives or caregivers also provided information, and the best source of information 
was used. Relatives were interviewed in two thirds of the cases in Papers I-III. The 
author of this thesis conducted all the interviews in Paper I and IV and the majority 
of those in Paper II and III. The remaining were conducted by two research assistants, 
both experienced clinicians, who also had access to discuss scoring with the first 
author at any time. 
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We used a revised Norwegian translation of the GOSE in Paper II-IV. This was 
developed in 2007, by a national collaboration where the author of this thesis 
participated. 
3.5.2 Employment and productivity 
Employment was defined as paid work; full time or part time, even in 
combination with other governmental benefit. Housekeeping was rated as 
employment only if there were children in the family. 
Productivity defines either paid work or participation in education without 
special adjustments.  
3.6 Neuropsychological assessment  
Neuropsychological assessment was performed at three months post-injury using 
a comprehensive battery of neuropsychological tests designed to cover the domains 
typically affected by TBI; attention, information processing speed, executive 
functions and memory. The test battery is shown in Table 3 in Paper IV. The 
assessment was part of a clinical follow-up, and test results, as well as the 
psychologist’s clinical evaluation, were also used to guide subsequent rehabilitation 
interventions. Testing was performed by trained psychologists, one test technician 
and two master-level students at the Brain Injury Unit at the Department of Physical 
Medicine and Rehabilitation, St. Olavs University Hospital. 
Raw scores were used, and they were also converted to standard scores by use of 
the material provided by the manufacturers of the tests, except for the SDMT; where 
a normative sample quoted by Lezak [83] was used. For a more detailed explanation, 
see section 1.9.1 
3.7 Statistical methods 
Statistical analyses have been described in detail in the individual papers, and 
some statistical considerations are also included in the Discussion section 5.1.6.  
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CHAPTER 4 SUMMARY OF RESULTS 
4.1 Paper I 
Objective: To assess long-term outcome in survivors after severe head injury 
and relate outcome to injury severity.  
Design: Follow-up 3-8 years post-injury in a retrospectively collected sample. 
Setting: A neurosurgical department in a regional trauma centre. 
Subjects: Of 146 individuals admitted, 135 were actively treated. Twenty-four 
percent of these died within six months. Ninety-three of the 94 (age 1-88) who 
survived more than three years, were included in the follow-up. They were separated 
into groups based on their level of consciousness at four weeks post-injury: oriented 
(n =39), confused (n = 22) or in a minimally conscious/vegetative state (MCS/VS) 
(n=26) and not possible to assess (n = 6).  
Outcome measures: Glasgow Outcome Scale Extended (GOSE), participation in 
work/education (productivity) and post-traumatic epilepsy (PTE).  
Results: GOSE scores were: vegetative state: 3%, severe disability: 28% (22% 
lower level, 6% upper level), moderate disability: 39% (22% lower level, 17% upper 
level), and good recovery: 27% (10% lower level, 17% upper level). Productivity 
was 34% (age 7- 64). The three severity groups had different GOSE scores (p< 
0.001) and different proportion of productive individuals (p< 0.001). Twenty-three 
percent experienced PTE, and PTE was significantly associated with the highest 
injury severity (p<0.001) and intracranial surgery (p=0.01). 
Conclusions: Being independent in daily life, but unable to work, was the 
typical long-term outcome. Stratifying the patients based on consciousness at four 
weeks, we found different outcomes. Among oriented patients, almost all regained 
independency, whereas in the most severe group, poor outcomes and PTE were 
common.  
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4.2 Paper II 
Objective: In this prospective cohort study we examined patients with moderate 
to severe head injuries with magnetic resonance imaging (MRI) in the early phase. 
The objective was to explore the occurrence of diffuse axonal injury (DAI) and if 
DAI was related to level of consciousness and patient outcome. 
Methods: One hundred and fifty-nine patients with Glasgow Coma Scale (GCS) 
score 3-13, were admitted from Oct 2004 to Aug 2008 (age 5-65 years and surviving 
the acute phase). Out of these, 106 patients were examined with MRI within four 
weeks post-injury. Three stages of DAI were used; stage 1: lesions confined to the 
lobar white matter, stage 2: callosal lesions and stage 3: lesions in dorsolateral brain 
stem. Outcome measure was Glasgow Outcome Scale Extended (GOSE) 12 months 
post-injury. 
Results: DAI was detected in 72% of the patients and a combination of DAI and 
contusions or hematomas was found in 50%. GCS score was significantly lower in 
patients with “pure DAI” (median 9) than in patients without DAI (median12; 
p=0.001).  GCS score was related to outcome only in patients with DAI (r=0.47; 
p=0.001). Patients with DAI had GOSE score 7, and patients without DAI had GOSE 
score 8 (p=0.10). Outcome was better in patients with DAI stage 1 (median GOSE 
score 8) and DAI stage 2 (median 7.5) than in patients with DAI stage 3 (median 4; 
p=0.001). Thus, in patients without any brain stem injury, there was no difference in 
good recovery between patients with DAI (67 %) and patients without DAI (66 %). 
Conclusion: Diffuse axonal injury was found in almost three-quarters of patients 
with moderate and severe head injury who survived the acute phase. DAI influenced 
the level of consciousness, and only in DAI patients was GCS score related to 
outcome. Finally, DAI was a negative prognostic sign only when located in the brain 
stem.  
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4.3  Paper III 
Object: To describe the prevalence and impact of traumatic brainstem lesions in 
patients with moderate and severe head injury surviving the acute phase. 
Furthermore, we sought to explore the prognostic value of depth of lesions depicted 
with early magnetic resonance imaging (MRI).  
Methods: In a cohort of 159 consecutive patients with moderate to severe head 
injury (age 5-65 years and surviving the acute phase) admitted to a regional level 1 
trauma centre, 106 (67%) were examined with MRI within four weeks post-injury. 
Depth of lesions in MRI was categorized as: hemispheric level, central level, and 
brainstem injury (BSI). Outcome measure was Glasgow Outcome Scale Extended 
(GOSE) 12 months post-injury.  
Results: Forty-six percent of patients with severe injuries and 14 % of patients 
with moderate injuries had BSI. In severe head injury, central or brainstem lesions in 
MRI together with higher Rotterdam CT score, pupillary dilatation and secondary 
adverse events were significantly associated with a worse outcome in age adjusted 
analyses. Bilateral BSI was strongly associated with a poor outcome in severe injury 
with positive and negative predictive values of 0.86 and 0.88, respectively. In 
moderate injury, only age was significantly associated with outcome in multivariable 
analyses. 
Conclusion: Almost half of patients with severe head injury, but also some with 
moderate injury, had BSI depicted with MRI. In patients with severe head injury, 
surviving the acute phase, depth of lesion in the MRI was associated with outcome, 
and in particular, bilateral brainstem injury was strongly associated with poor 
outcome. In moderate head injury, surprisingly, there was no association between 
MRI findings and outcome when using the GOSE as outcome measure. 
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4.4 Paper IV 
Objective: To explore the magnitude and frequency cognitive impairments three 
months after moderate and severe traumatic brain injury (TBI) and study their 
relation to presence of complaints or disability at one year follow-up. 
Design: Follow-up study 
Setting: Patients prospectively included from a regional level I trauma center. 
Participants: Patients (aged 13-65 years) with definite TBI; i.e. Glasgow Coma 
Scale  score 3-13 and injury documented by magnetic resonance imaging (n = 61) or 
computer tomography (n = 2) and 48 healthy volunteers. 
Interventions: Not applicable 
Main Outcome Measures: Neuropsychological assessment covering motor 
function, information processing speed, attention, visual and verbal memory, 
working memory and executive functions and Glasgow Outcome Scale Extended 
(GOSE). 
 Results: Subjects with TBI performed worse than controls; most consistently 
regarding information processing speed and verbal memory. However, only 2- 44 % 
of subjects with TBI had clinically impaired test scores defined as < 1.5 standard 
deviations below mean of normative data. Based on a selection of nine tests, 0-1 
impaired score was seen in 47 of 48 (98 %) of controls and in 21 of 37 (57 %) after 
moderate and 9 of 24 (34 %) after severe TBI. At one year post-injury, disability or 
complaints affecting daily life, reflected by GOSE score  7, were seen in 74 %  of 
those with 2  impaired test scores and in 43 % of those with 0-1 impaired score 
(p=0.017).  
Conclusions: In this sample of patients with recent, definite TBI and healthy 
volunteers, presence of cognitive impairment was specific to TBI and associated with 
future complaints or disability. However, the tests demonstrated low sensitivity to 
TBI, and many experienced complaints affecting daily life at 12 months post-injury 
despite a seemingly normal test performance. 
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CHAPTER 5  GENERAL DISCUSSION 
5.1 Methodological issues 
5.1.1 The study population 1998-2002 
This sample, studied in paper I, was characterized by injury-related variables that 
were collected retrospectively by review of medical records. Since this information 
was not recorded for the purpose of research, the injury related variables are 
probably less accurate than those collected in a prospective study. Strength of the 
study of this sample was that it comprised only individuals with severe TBI, and 
hence was more homogeneous than the prospective sample. The study was hospital-
based; that is, we included foreigners and inhabitants of other parts of the country if 
admitted to the hospital, and we did not collect similar data of inhabitants of our 
region who had been treated for severe TBI in other regions. Still, the hospital is the 
only level I trauma center in the region, and almost all participants lived in the region, 
and thus we believe the data provide estimates of a complete sample of severe TBI, 
as is also discussed below in section 5.1.4. 
5.1.2 The study population 2004-2009 
This sample consisted of patients with moderate as well as severe injuries, and 
thus the sample was more heterogeneous. As will be discussed below, one interesting 
finding from this study was that, actually, these groups might not be confidently 
analyzed together in studies of prognosis. This study population is a cohort of 
individuals with TBI where data are collected prospectively, thus yielding stronger 
evidence. The participation rate for follow-up in the cohort is 97 %, and for the data 
collection at 3 (Paper IV), 6 and 12 months (Paper II and III), loss to follow-up was 
only around 1 %.  
We included patients with GCS score 13, a score defining mild TBI in some 
previous studies. However, most of the patients with GCS 13 described in Papers II- 
IV had PTA duration >24 hours, and thus should have been classified as moderate 
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TBI according to several recommendations [21, 121]. Furthermore, there is an 
increasing trend to classify patients with GCS score 13 as moderate TBI [104, 144].  
5.1.3 The control group 
In Paper IV, the test scores of the individuals with TBI are compared with those 
of a reference group. The purpose of the comparison was to make inferences of how 
the brain injury had affected cognition, and thus, the reference group should be 
representative for the patients with TBI before they sustained their injury. All 
reference samples are usually selected to be representative regarding age and sex, but 
in addition, we also matched the samples for years of education. This is common 
practice in neuropsychological research as education is associated with performance 
for some tests. Some researchers argue, however, that this is not sufficient to obtain 
groups that represent the same underlying population [36].  
In paper I, we observed some differences regarding the IQ scores that probably 
in part reflected premorbid functioning, and thus, we agree that the choice of control 
group is a relevant concern. Next, however, it is not simple to address this accurately. 
First, it is not well known which characteristics or traits that indicate susceptibility to 
the diverse mechanisms causing head trauma, and by no means would it be easy to 
measure these validly. This issue is also discussed in the context of confounding in 
section 5.1.6.  
In a quantitative review of the effects of TBI, the choice of control group was 
studied.  Studies using control participants with orthopaedic injuries, seemingly 
demonstrated somewhat smaller effect sizes, but this was not significant, and they 
concluded that control groups should not necessarily be selected on the base of such 
a priori concern [130]. Others have used non-head trauma controls treated in 
intensive care units [78]. This approach admittedly adjusts for many trauma-related, 
potentially harmful effects that can add up to the brain injury in TBI, but when the 
trauma is this severe, later disability is frequent [86], and methodological concerns 
may still be present. Furthermore, unrecognized diffuse brain injury, either primary 
or secondary must be carefully ruled out.  
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5.1.4 Reliability and validity of the measures 
For some of the measures and variables used in this thesis, reliability and validity 
should be discussed. 
The GCS scoring is the standard procedure for evaluation of coma or impaired 
consciousness in head trauma, and an important advantage is that it is simple and 
quick to administer. Furthermore, it is a common measure, used in all head injury 
research across the world, and thus may not easily be replaced. The GCS has lost 
some of its power as prognostic factor, probably due to the increased use of pre-
hospital intubation [145]. The GCS score at the scene of accident may be influenced 
also by alcohol or other substances or by other factors often present in major trauma 
(hypothermia, hypoxia or hypotension) [97]. Actually, it has been reported that a 
GCS motor score of 2 (extension of limbs to pain; a positively observed, severe 
neurological sign) was associated with a worse prognosis than the more common 
score of 1 (no reaction observed), which may have several causes [8].  
In our studies, the GCS score was corrected if initial GCS score clearly was 
affected by non-trauma factors, and the clinical course demonstrated a rapid rise to 
near normal values, a course not usually seen in moderate or severe injuries. This 
was a clinical judgment, performed by a few experienced clinicians in the project, 
and not a standardized procedure (as no such exists). In some of these cases, we were 
not able to assign the patient to an exact GCS score. Thus, we also use broader 
categories. With the experience from assigning GCS scores in this cohort, we believe 
that this is a problem in all trauma series; still this problem is not always accounted 
for.  
PTA was not consistently assessed with rating scales developed for this purpose. 
Ideally, this should have been done. However, this was a clinical series of patients 
who were often transferred to local hospitals while still in PTA. It would have been 
practically impossible to track all patients with for instance the Galveston orientation 
and amnesia test (GOAT) [82], as the scale is most familiar in rehabilitation hospitals, 
and many of the patients in our studies did not receive in-patient rehabilitation. 
Rather than omitting information of PTA from the study protocol, we chose to use 
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the same kind of estimation that we apply in the clinical setting; gather information 
about confusion from records and staff in addition to own observations.  
Furthermore, we chose to describe PTA according to fixed time points rather 
than as duration exactly in days. This makes sense, as it is difficult to obtain really 
valid and trustworthy exact PTA duration in many cases. The time period of sedation 
is sometimes lengthened by other factors than the state of the brain, for instance chest 
trauma or repeated orthopaedic surgery. If the patient is out of PTA at the end of 
sedation, its duration in days is unknown. Patients who have been sedated for a 
lengthy period of time may suffer from withdrawal symptoms, and the assessment of 
PTA will be difficult. Thus, in the end, assessing PTA, inevitably involves an 
element of clinical judgement. Just as with the GCS scores, we believe that this must 
be a matter in all TBI studies, but it is seldom explained.  
The MRI and CT variables that were used in paper II and III, were based on 
visual inspection of scans, and thus also possibly biased by subjectivity of the raters. 
Regarding the MRI evaluation; this was addressed in our study of inter-rater 
agreement, as little is known from the literature. The kappa values indicated good 
inter-rater agreement. Ideally, the MRI examinations should have been standardized 
regarding time from injury to scanning. This was not possible as MRI was carried out 
without specific resources, and we had to fall into line with activities in other 
respects at the intensive care unit and the MRI lab. Neither would the clinical 
condition of all patients with severe TBI, and other traumas too, be stable enough for 
MRI at a given time.    
The GOSE is an outcome measure developed to meet some weaknesses of the 
original GOS. Its reliability has been demonstrated (see also section 3.5.1) but recent 
studies have shown lower inter-rater reliability in the telephone setting [81] and in 
multicenter studies [166]. These papers also offered some solutions to reduce these 
concerns, which were followed in our work. One may also criticize that assessors of 
outcome in our studies had access to clinical information. According to the American 
Academy of Neurology’s criteria for classes of evidence, this weakens the 
conclusions to be drawn. Still, we will argue that in a telephone setting, clinical 
experience and insight into the severity of the injury makes it less likely that falsely 
high scores were assigned in patients with poor self-awareness. Actually, there may 
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be a trade off in the outcome assessment between minimizing bias and reducing 
mistakes. 
Reliability and validity of neuropsychological tests is a major issue, and a 
detailed description is beyond the scope of this thesis. Typically, data regarding 
reliability and validity are given for the different tests by the manufacturer, and are 
also listed in compendiums of tests [146]. One issue relevant for the study in Paper 
IV is inter-rater reliability. The neuropsychological testing was carried out by several 
psychologists and test technicians. In a research project, it would have been optimal 
if just one or two had been involved. To compensate for errors associated with 
several examiners, the protocol was carefully described for the research project, and 
all were supplied with oral and written instructions regarding for instance the order 
of the tests and scoring procedures.  
Neuropsychological tests have been criticized for low ecological validity; that is 
their ability to measure the real difficulties of the patients [23]. This was probably 
one explanation to the findings described in Paper IV; that many of the individuals 
with TBI performed in the normal range on traditional neuropsychological tests, but 
still reported injury-related complaints.  For researchers, and especially Non-English, 
this problem is not easy to address. There have been developed tests specifically for 
measuring everyday problems, especially for the executive domain, but not all of 
these have been translated into Norwegian or been validated in Norwegian samples. 
We did not include any tasks measuring effort, or symptom validity. Albeit 
regarded more essential in the assessment of mild TBI, a majority of the patients had 
been injured in traffic accidents and will eventually be involved in litigation. We did 
not, however, experience that patients were concerned about compensation this early 
after the injury. Furthermore, other issues, like fitness to drive, were often addressed 
concurrently with the first assessment, and our impression was that the patients were 
motivated and performed with effort. 
5.1.5 Internal and external validity of results 
Internal validity describes the degree to which the results are representative for 
the population that was studied. The studies in this thesis describe rather complete 
(Paper I), or fairly representative (Paper II and III) TBI samples treated in our 
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hospital. Thanks to the high participation rate and the loss to follow-up near zero, we 
have reduced the sources of bias and sampling error to an acceptable level, and we 
believe that the internal validity of the studies was acceptable.  
External validity is the degree to which the findings generalize to other settings, 
and is evaluated by comparing findings between similar studies from different places 
or by applying the same models or analyses on other datasets. One example of higher 
internal than external validity of results is that, internally, we found similar rates of 
severe disability after severe TBI in Paper I and Paper II, whereas in another 
Norwegian follow-up study, the authors found lower frequency of long-term severe 
disability [4]. Certainly, there were some differences in sample size, patient 
selections and loss to follow-up, but this may also illustrate the issue of 
generalization.  
One potential source of error is the reliability of the measures for use at several 
places. It has been shown for the Functional Independence Measure (FIM) that inter-
rater reliability was only fair for scorings at different facilities [75], and also for two 
of our key measures, the GCS and the GOSE [166], reliability has been questioned. 
An example of this was possibly demonstrated by two concurrent Norwegian 
publications of the incidence of hospital treated head injury; both reported figures of 
mild, moderate and severe head injury separately.  In the study from the Stavanger 
region, the authors reported to have admitted 77 patients with severe head injury 
during one year in a hospital serving 385 000 inhabitants [60], and this is four times 
the incidence reported by the authors of a study from Ullevål University Hospital, for 
the municipal of Oslo, with 534 000 inhabitants, reporting 27 cases during one year 
[5].  
In the study in Paper I, we found an incidence of severe head injury that was just 
below what was found from Oslo (4 versus 5 per 100.000 inhabitants per year), 
furthermore in the study in Paper I, we may have missed some cases of elderly, 
severely injured patients dying at their local hospital. Thus, we consider that our 
result strongly support the findings from Oslo. 
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5.1.6 Confounding, effect modification and the concern of low power 
Confounding and effect modification are potential sources of error associated 
with observational studies [58]. These are complex issues, and for a satisfactory 
description, textbooks should be consulted [119]. A confounding factor is one that is 
associated with both the dependent variable and the explanatory variable, but is not a 
part of the causal chain. The presence of confounding factors may lead to an under- 
or overestimation of the effect of the explanatory variable. In observational studies, 
confounding factors are controlled for by stratification, subgroup analyses or by 
applying multivariable statistical methods. 
Effect modification, or interaction, is present if the strength of the effect of an 
exploratory variable differs within strata of the sample. This is best dealt with by 
stratifying the sample.  
In the field of TBI, these are very relevant issues as there is substantial 
heterogeneity within TBI samples. But even if some strategies to address the 
problems are recommended, there are challenges to overcome. 
First, the sample needs to be large in order to run stratified analyses, subgroup 
analyses or analyses with many covariates. Certainly, very large studies exist as 
described in section 1.8.1. In these large scale studies, however, resource-demanding 
data as MRI or neuropsychological test scores have not been collected. Our MRI 
studies (Paper II and III) were not small compared with other studies, but in a much 
larger study, it would have been possible to include more covariates in the models 
and the odds ratios presented would have been more accurate. 
Second, the confounder must be acknowledged by the researchers, and variables 
must exist that can describe or quantify the confounding factor, in order to adjust for 
it. One example of this challenge was demonstrated in Paper IV, where we found that 
patients who sustain TBI probably deviate somewhat from the general population. 
We found evidence of this by assessing general intellectual abilities. But this is 
probably just a surrogate marker of a personality trait associated both with higher 
risk of accidents and lower compliance at school. It is possible that this “factor” is 
related also to performance on other neuropsychological tests, and thus may 
confound the effect of TBI on cognition. Ideally, this should be controlled for, but 
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this is not straight forward, as there are no questionnaires or scales with 
demonstrated psychometric properties, assessing premorbid personality for use after 
a brain injury. 
In paper II, we demonstrated that GCS score was lowest in patients with DAI, 
and also that it correlated with outcome only in this group. Thus, the variable that is 
uniformly used to adjust for injury severity may indeed be differentially related to 
outcome variables in subgroups of patients. Consequently, for conclusions to be valid 
also for patients with more focal injuries, other variables should be used to control 
for injury severity, but which would that be?  
In paper III, we had to perform analyses separately for moderate and severe 
injuries, as we could demonstrate that having a deep lesion in the MRI was 
associated with a worse outcome in patients with severe injuries, but not in those 
with moderate. This indicates that moderate and severe injuries might not be 
included in the same model. 
Another example of possible confounding appeared in Paper IV, as we 
demonstrated that there was a difference in the intellectual abilities of male and 
female patients with TBI. As discussed above, individuals at risk for accidents may 
differ from the normal population in some respects, but we have not seen any studies 
reporting sex differences regarding this issue. In TBI samples, 70-80 % of the 
patients are male, and this illustrates how large samples would need to be in order to 
generate sound evidence of the effect of TBI in women. The possible difference 
regarding  personality traits or socio-economic background for men and women with 
TBI, might be of interest for the research focusing on possible differences in 
outcome of TBI in men and women; some of them also exploring effects of the 
female sex hormones on the brain [142]. 
5.1.7 Was it just an observational study? 
The study design was best characterized as an observational study, as we did not 
intend to analyze effects of a specific intervention. Regarding the TBI population 
studied in Paper I, their outcomes could not be influenced by the mere fact of being 
studied, due to the partly retrospective design. In the prospective cohort study, 
however, this was different. Here, the procedures necessary for identification of 
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patients, for obtaining the informed consent and for collection of the follow-up data 
actually represented improvements in the clinical management and patient education 
as well. The phone calls were mostly made by the author of this thesis, who is 
experienced in brain injury rehabilitation and who was also familiar to the relatives 
due to the inclusion procedure. Furthermore, we believe that before the Head Injury 
Project, delay of rehabilitation or discharge without any scheduled follow-up was 
more common. Thus, when outcomes are to be evaluated against other settings, it is 
also necessary to compare what kind of rehabilitation and follow-up that has been 
offered to the patients.  
5.2 Importance and clinical implications of the main findings 
5.2.1 The frequency and impact of diffuse axonal injury 
Diffuse axonal injury, visible in MRI scans, was found in almost three-quarters 
of patients with moderate and severe head injury who survived the acute phase. It is 
commonly believed that the conventional MRI examination is rather insensitive to 
DAI, and thus we consider that Paper II convey important new evidence of the 
prevalence of DAI detected by MRI. However, in almost half of the patients with 
moderate injury, no lesions compatible with DAI was found. If one assumes that all 
TBI essentially result in a component of DAI, then this MRI protocol was not 
sensitive enough, and hopefully in the future, clinical scan protocols will also include 
DTI. Yet, given the difference regarding GCS discussed below, possibly the cases 
without DAI actually were more focal or multifocal of nature in a way that makes 
sense, clinically. 
We demonstrated that the presence of DAI stage 2; a callosal lesion, was not a 
negative prognostic sign in the absence of DAI lesions in the brain stem. Thus the 
proposed staging of DAI did not represent a successive increase in clinical severity. 
5.2.2 The dissociation of GCS scores in DAI and contusions  
In Paper II, we found that DAI influenced the level of consciousness, and only in 
DAI patients was GCS score related to outcome. Thus, in patients with contusions, 
but no evidence of DAI, one has to consider other factors than GCS score in 
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evaluation of severity and prediction of outcome. Also in the medico-legal context, 
this may be informative to experts; a high initial GCS should not be used as evidence 
against significant brain injury in cases of cortical contusions.  
5.2.3 The characteristics of brain stem injury 
We reproduced the previous finding of two types of primary brain stem lesions. 
When a brain stem lesion was found in a patient with moderate TBI, this was always 
unilateral, and these patients had a similar outcome as those without such lesions. 
Neither were unilateral DAI lesions in the brain stem associated with a poor outcome. 
Thus, it is important that clinicians hold a differentiated view of the implications of 
brain stem injury. 
5.2.4 The clinical value of MRI
In Paper III important findings were (a) the high predictive value; positive and 
negative, of demonstrating a bilateral brain stem injury in surviving patients, and (b) 
the almost universal demonstration of parenchymal lesions. 
Even with the inclusion of patients with GCS score of 13, we found evidence of 
traumatic parenchymal brain lesions in virtually all patients. Some patients had also 
sustained multi-trauma, and if the initial cerebral CT scan was negative, the surgeons 
naturally focused on the management of other traumas rather than the GCS score at 
the scene of accident. We repeatedly experienced that neither the patients nor the 
professionals were aware of the possible cerebral injury, and thus MRI became the 
only objective documentation of a brain injury.  
5.2.5 The difference between moderate and severe injury 
In Paper III the separate analyses of moderate and severe TBI resulted in some 
important findings. In individuals with moderate TBI, first of all, we found that 
global outcome was generally better than in severe TBI and that practically all 
achieved a favourable outcome and thus could live independently. Second, some of 
the traditional prognostic factors, like GCS score, pupillary dilatation and findings 
from neuroimaging [99] were not predictors of outcome. Age, however, was a strong 
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prognostic factor, and the proportion experiencing a good outcome was much higher 
in the young patients than in those older than 35 years.  
In severe TBI the well known prognostic factors were more predictive, but also 
in this group, prediction of death and severe disability was more accurate than 
prediction of level of disability in the upper range of outcome.  
It is important that researchers become aware of this. Effects may be accounted 
for solely by subgroups within the sample, and there is a risk that effect 
modifications are present in multivariable analyses.  
5.2.6 The high rate of normal test performance 
Patients were cognitively impaired compared with healthy controls, and effect 
sizes of severe TBI were large, and thus in line with previous reports [130]. However, 
even when effect sizes are large, there is 50 % overlap between the two groups. In 
Paper IV, we studied deviations from normative data in individual cases of TBI. 
With this approach, we demonstrated that more than half of the individuals with 
moderate TBI, and even one third of those with severe TBI, performed almost 
indistinguishably to healthy controls. Possibly, these individuals have normalized 
their cognitive functioning, but since 43 % of those with normal assessment 
experienced some injury-related disability or complaints reflected in GOSE score  7 
at one year follow-up, low sensitivity or poor ecological validity of the tests may also 
explain this. 
 Our findings might contribute to a differentiation of the discussion of how to 
interpret the neuropsychological assessment, especially in the medico-legal context. 
Lately, there has been a strong emphasis on the high rate of abnormal findings in 
healthy persons, on methods for detecting malingering and on the effect sizes of 
other conditions, like depression. Yet, we must not forget that individuals with TBI 
may suffer from relevant, cognitive decline that the neuropsychological tests do not 
convincingly verify. Hopefully, in the future, use of more sophisticated imaging and 
neurophysiologic methods will supply the tests as diagnostic tools and improve our 
understanding and diagnosing of the true impact of TBI.   
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5.2.7 The risk of severe disability after head injury 
One important finding in Paper I, which was confirmed in Paper III, was that 
also samples of only severe TBI comprise patients with very different outcome. We 
found that one third of those surviving a severe TBI (31 % in paper I and 33 % in 
Paper III) eventually experienced long-lasting, severe disability, in line with the 
study from Glasgow [162]. In Paper I we showed that patients who were still in a 
minimally conscious state or even worse, at four weeks post-injury were those at risk 
of severe disability. In Paper III, we further extended the knowledge of risk factors 
for severe disability by demonstrating the strong association with bilateral brain stem 
injury. This is important information to clinicians and researchers. This group of 
patients benefits from early intensive rehabilitation and should be given high priority 
for in-patient rehabilitation in specialized clinics [55, 132]. Knowledge of the future 
risks and needs of these patients can improve our ability to focus rehabilitation 
interventions and design research projects aiming at minimizing their disability.  
5.2.8 The risk of falling outside working life 
In paper I, a disappointing finding was that individuals who had suffered severe 
TBI, had just as high risk of falling outside working life as was shown decades ago 
[18]. We found that the clinical condition four weeks post injury was predictive of 
future work status. In the group of patients who were in the minimally conscious or 
vegetative four weeks post-injury, employment rate was zero. Even if ordinary, 
competitive work position may be unrealistic in this subgroup, many of these are 
individuals who may well participate in working life; provided qualified and lengthy 
support and suitable workplaces.  
In the subgroup of individuals who had been oriented by four weeks, two thirds 
were able to work or study without special adjustment. Future studies should explore 
with more scrutiny which were the factors responsible for successful employment in 
this subgroup.  
In summary, rehabilitation professionals should acknowledge the real chances of 
employment; set up realistic goals and tailor the intervention to the needs of the 
individual from the first day on.  
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5.2.9 The difficulty of predicting a good recovery 
No wonder, a full recovery is the initial goal for everyone sustaining a head 
injury. In our studies, we experienced that predicting outcome in the upper range is 
more difficult than predicting severe disability.  In individuals with moderate TBI, 
among the traditional prognostic factors, only age was predictive of outcome. 
Furthermore, having measurable cognitive impairments at three months post-injury 
was associated with later complaints, but this was not studied in multivariable 
analyses, and neither was the association strong enough to be really useful. 
When the damage of brain tissue is less extensive, probably a wider spectrum of 
factors influences the biological recovery of the brain as well as the coping and 
adaptation of the individual as illustrated in the WHO’s International Classification 
of Functioning, Disability and Health, ICF (Fig 5.2.1) [2]. This illustrates the 
methodological challenges associated with outcome research in patients with less 
severe brain injuries. A broad selection of explanatory variables should be applied; 
they must be valid and reliable, and collected in a really large sample of patients. The 
development of core sets according to the ICF is a promising step to progress in this 
field [13]. 
 
 
Fig. 5.2.1. The ICF model. 
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CHAPTER 6   FUTURE PERSPECTIVES 
A vision and source of motivation has been that these studies should be just the 
beginning of multidisciplinary TBI research in our hospital. During this work, a 
foundation for future studies has been created, and the perspectives are exciting.  
In another few years, the sample size of moderate as well as severe head injuries 
will be large enough to separately analyze outcome in relation to a wider range of 
prospectively collected variables. Another interesting future project will be that of 
the 5 years outcome assessment. This includes quality of life, using the new measure; 
QOLIBRI (Quality of Life after Brain Injury) and questionnaires on reported 
psychological health and TBI related complaints. We plan to collect more detailed 
information of vocational status and also of which services and interventions that 
have been offered to the individuals regarding vocational rehabilitation.  
The individuals subjected to neuropsychological testing, were tested at 12 
months too, and for the time being, we also perform testing of more individuals 12 
months after TBI. Thus we increase the sample size and eventually will be able to 
compare patients with different patterns of MRI findings, which we originally 
planned for this thesis, not realizing how few patients there would be without DAI.  
We may also explore the relationship between cognitive functioning at 3 months 
as well as 12 months with the outcomes recorded at 1 and 5 year follow-up.  
Furthermore, MRI was performed again at 3 and 12 months post-injury in the 
same subset of the patients, including a 3D sequence for volume computation. The 
longitudinal evolution of MRI characteristics will be included in future studies of the 
project.  
Finally, during the last year, many of the patients in the cohort and also the 
majority of the controls have consented to participate in a study where DTI, different 
functional MR imaging paradigms as well as ERP and quantitative EEG are used to 
characterize brain structure and function. These will be related to outcomes on the 
level of activities and participation as described above as the 5 year outcome 
measures. 
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CHAPTER 7  CONCLUSIONS 
Paper I 
  
Being independent in daily life, but unable to work, was the typical long-term 
outcome. Stratifying the patients based on consciousness at four weeks, we found 
different outcomes. Among oriented patients, almost all regained independency, 
whereas in the most severe group, poor outcomes and PTE was common. 
 
Paper II and III 
 
Diffuse axonal injury was found in almost three-quarters of patients with 
moderate and severe head injury who survived the acute phase. DAI influenced the 
level of consciousness, and only in DAI patients was GCS score related to outcome. 
DAI was a negative prognostic sign only when located in the brain stem.  
Depth of lesion in the MRI was associated with outcome, and in particular, 
bilateral brainstem injury was strongly associated with poor outcome. In moderate 
head injury, surprisingly, there was no association between MRI findings and 
outcome when using the GOSE as outcome measure. 
 
Paper IV 
 
In a sample of patients with recent, definite TBI and healthy volunteers, presence 
of cognitive impairment was specific to TBI and associated with future complaints or 
disability. However, the tests demonstrated low sensitivity to TBI, and many 
experienced complaints affecting daily life at 12 months post-injury despite a 
seemingly normal test performance. 
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Cognitive Impairment Three Months After Moderate and 
Severe Traumatic Brain Injury. A prospective follow-up study. 
Toril Skandsen, MD, Torun G Finnanger, Cand Psychol, Stein Andersson, Cand Psychol, PhD, 
Stian Lydersen, PhD, Jan F Brunner, Cand  Psychol, Anne Vik, MD, PhD  
 
Objective: To explore the magnitude and frequency cognitive impairments three months after 
moderate and severe traumatic brain injury (TBI) and study their relation to presence of 
complaints or disability at one year follow-up. 
Design: Follow-up study 
Setting: Patients prospectively included from a regional level I trauma center. 
Participants: Patients (aged 13-65 years) with definite TBI; i.e. Glasgow Coma Scale  score 3-
13 and injury documented by magnetic resonance imaging (n = 61) or computer tomography (n = 
2) and 48 healthy volunteers. 
Interventions: Not applicable 
Main Outcome Measures: Neuropsychological assessment covering motor function, 
information processing speed, attention, visual and verbal memory, working memory and 
executive functions and Glasgow Outcome Scale Extended (GOSE). 
 Results: Subjects with TBI performed worse than controls; most consistently regarding 
information processing speed and verbal memory. However, only 2- 44 % of subjects with TBI 
had clinically impaired test scores defined as < 1.5 standard deviations below mean of normative 
data. Based on a selection of nine tests, 0-1 impaired score was seen in 47 of 48 (98 %) of controls 
and in 21 of 37 (57 %) after moderate and 9 of 24 (34 %) after severe TBI. At one year post-injury, 
disability or complaints affecting daily life, reflected by GOSE score  7, were seen in 74 %  of 
those with 2  impaired test scores and in 43 % of those with 0-1 impaired score (p=0.017).  
Conclusions: In this sample of patients with recent, definite TBI and healthy volunteers, presence 
of cognitive impairment was specific to TBI and associated with future complaints or disability. 
However, the tests demonstrated low sensitivity to TBI, and any experienced complaints affecting 
daily life at 12 months post-injury despite a seemingly normal test performance. 
 
Key words:  Craniocerebral Trauma; Neuropsychology; Prognosis; Neuropsychological Tests; 
Longitudinal Studies 
 
 2 
Cognitive impairment is a  common 
consequence of moderate and severe traumatic 
brain injury (TBI),1 particularly affecting 
information processing speed and attention,2, 3 
memory 4 and executive functioning.5 The first 
assessment is typically performed during the first 
months; when deficits are most evident. A 
common research design has been comparisons 
of mean test performances between subjects with 
TBI and a control group, and tests have typically 
been described as sensitive if highly significant 
differences have been found. The magnitude of 
the effect of TBI on cognition, effect size, may be 
expressed as Cohen’s d; the standardized 
difference of means in two groups. In a meta-
analysis, a large mean effect size (dpooled = 0.97) 
of TBI across studies was found for moderate to 
severe TBI within the first six months.  
In the individual clinical assessment, 
however, interpretation of neuropsychological 
test scores must be based on comparison with 
normative data. When evaluating whether a low 
test score reflects injury-related impairment, it 
should also be interpreted in relation to general 
intellectual capacity and performance on other 
cognitive tests 6, but the empirical basis for this 
subjective evaluation is currently debated7. In 
some settings, such as legal expert examinations 
and research, objective criteria of impairment 
should be sought, but there is no such general 
definition.7 The issue is further complicated by 
the fact that also healthy subjects perform below 
the normal range in some percentage of 
administered tests.7, 8  
In the meta-analysis by Schretlen & Shapiro, 
it was pointed out that while cases of moderate 
and severe TBI typically are analyzed together in 
neuropsychological research, they constitute a 
heterogeneous group. Thus, the reported effects 
might be overestimated for moderate TBI and/or 
underestimated regarding severe TBI.9  
For the present study we performed 
neuropsychological testing three months post-
injury as part of a large follow-up study in 
patients who were admitted with moderate and 
severe head injury to a regional level I Trauma 
center. We have previously, in a larger subgroup 
of the main cohort, demonstrated that virtually all 
the patients had parenchymal lesions detected 
with early magnetic resonance imaging (MRI). 
Diffuse axonal injury was frequently found as 
well as contusions; often in concert.10  
The aim of the present study was to explore 
the magnitude and frequency of cognitive 
impairments three months after moderate and 
severe TBI in comparison with healthy controls. 
Furthermore, we sought to relate cognitive 
functioning to concurrent and one year global 
functioning and to duration of post traumatic 
amnesia (PTA).  
METHODS
The Regional Committee for Medical 
Research Ethics and the Norwegian Social 
Science Data Services (NSD) approved the study 
and written consent was obtained from the 
patients and from parents of patients younger 
than 16 years.  
Participants 
Sixty-three patients (age 13-65) admitted to 
the Neurosurgical department, St. Olavs Hospital, 
Trondheim University Hospital, Norway 
participated in the study. The hospital is a Level I 
Trauma Center, and has an ongoing database that 
includes patients treated with moderate and 
severe head injuries according to the Head Injury 
Severity Scale (HISS) criteria 11 with no 
exclusion criteria. The project has achieved 97 % 
participation and only around 1 % loss to follow-
up of. For the present study, patients were invited 
to participate in neuropsychological testing at 3 
and 12 months post injury with the following 
inclusion criteria: (a) resolution of PTA before 
the time of testing as well as ability to cooperate 
during testing and (b) no ongoing substance 
abuse, diagnosed neurological or psychiatric 
condition or previous moderate to severe head 
injury according to the same criteria. The main 
inclusion period was from October 2004 to 
October 2007. During this period, 172 patients 
were admitted, of whom 169 consented to 
follow-up. Thirty-six died, 31 were outside the 
relevant age-group, 12 could not cooperate at 
three months, 17 were excluded due to premorbid 
conditions, 7 refused all testing, 9 preferred 
testing locally, 2 were not fluent Norwegian 
speakers and 1 was lost to follow-up. Thus, fifty-
four patients were included, and these constitute 
86 % of the study sample. The remaining nine 
patients were recruited among patients who 
geographically belonged to our hospital and were 
seen for a three months follow-up evaluation 
during 2008 and 2009. The control group 
consisted of 48 healthy persons, matched for age, 
sex and education, recruited via advertisements, 
among family and friends of patients with head 
injury and among acquaintances of researchers 
and staff.  
Injury-related variables   
These were mechanism of injury, MRI 
findings, Glasgow coma scale (GCS) score 
(scoring procedures have been described in an 
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earlier publication10), injury being moderate 
(GCS score of 9-13) or severe head injury (GCS 
score of 8). Duration of PTA, defined as the 
period of posttraumatic confusion,12 was 
evaluated by the first author as a clinical 
judgment during the first few weeks based on 
medical notes or clinical assessments. It was 
classified as lasting < 1 week or  1 week, a cut-
off point previously associated with high rates of 
good recovery.13  
MR imaging  
MR imaging (1.5 Tesla) was performed at 
median 10 days post injury (range 1-120). The 
scan protocol included T1 and T2- weighted 
sequences, a T2*-weighted gradient echo 
sequence, fluid-attenuated inversion recovery 
(FLAIR) sequences and diffusion-weighted 
imaging. MRI parameters and procedure of 
evaluation have been reported previously.10  
Procedures for neuropsychological testing and 
scoring 
Neuropsychological assessment was 
performed at mean 98 (± 10) days post-injury. 
Testing was performed by psychologists, master 
level students and test technicians at St. Olav 
University Hospital. Raw scores were converted 
to standard scores by use of normative data 
provided by the manufacturers of the tests, except 
for the Symbol Digit Modality Test; where a 
normative sample quoted by Lezak was used.14 
Standard scores were given as T-scores, Scaled 
scores (S-scores), Z-scores or percentiles. An 
individual’s standardized test score was classified 
as impaired if it was below 1.5 standard deviation 
(SD) according to the reference norms for the test 
(T-score  34, S-score  5; Z-score  -1.5 or 
percentile  5).  
Neuropsychological measures 
The four subtests of the Wechsler 
Abbreviated Scale of Intelligence (WASI),15 
were administered to estimate general intellectual 
capacity. In order to avoid future retest effects in 
a planned reassessment, we used a split-half 
procedure, and a raw score was estimated. The 
control participants were tested once, with all 
items, and raw scores were calculated after the 
same procedure. The following 
neuropsychological methods were used to assess 
different domains of cognitive function: 
I. Motor function: Grooved Pegboard, 
dominant  16; Trail Making Test (TMT), 
condition 5 (motor speed) from the Delis Kaplan 
Executive Function System (D-KEFS).17 
II. Information processing: Trail Making 
Test, condition 1 (visual scanning), 2 (number 
sequencing), and 3 (letter sequencing) ; Color-
Word Interference Test (CWIT), condition 1 
(color naming) and 2 (word reading) from D-
KEFS and Symbol Digit modality Test (SDMT), 
oral and written version.18 
III. Attention and vigilance: Conners’ 
Continuous Performance Test II (CCPT-II).19 
IV. Visual learning and memory: Continuous 
Visual Memory Test (CVMT)20; Taylor Complex 
Figure (TCF).21 The TCF was not administered to 
controls. Raw scores for the TCF were converted 
to standard scores based on normative data for 
the Rey-Osterrieth Complex Figure.22 
V. Verbal learning and memory: California 
Verbal Learning Test II (CVLT-II).23  
VI. Working memory: Digit Span Backwards 
from the Wechsler Adult Intelligence Scale - 
Third edition  (WAIS-III) 24; Letter-Number 
Sequencing from WAIS III. 
VII. Executive functions: Wisconsin Card 
Sorting Test (WCST), computer version25; 
Verbal Fluency Test from D-KEFS; TMT, 
condition 4 -Number-Letter Sequencing, from D-
KEFS; CWIT, condition 3 and 4 - Inhibition and 
Inhibition/Switching, from D-KEFS; Tower Test 
from D-KEFS. 
The different sub-scores obtained from each 
test are shown in Table 3 and 4. 
Global outcome 
Global functioning was assessed by the first 
author with GOSE at 3 and 12 months using the 
structured interview.26 GOSE score  7 denotes 
presence of head injury-related disability or 
complaints to a degree that they affect daily life.  
Statistical analysis 
Dependent variables were checked for 
normality in subjects with TBI and control 
participants by inspection of Q-Q plots. Raw 
scores for each test are presented as mean and SD 
for normally distributed data and otherwise as 
median with inter quartile range (IQR; the 25th 
and 75th percentile). Likewise, comparisons 
between subjects with TBI and control 
participants were performed by use of Student’s 
t-test and Mann-Whitney U test respectively. A 
Student’s t-test with unequal variance was used 
when Levene’s test gave evidence of variance 
heterogeneity. Effect sizes were calculated both 
as Cohen’s d based on pooled variance (dpooled) 
and as Glass’ d, where the denominator is the SD 
of the control group (EScontrol).27 For the tests 
where data were non-normally distributed, 
standardized effect size was estimated by 
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dividing the difference between the median 
scores by the IQR of controls x 0.75 (EScontrol).27 
Cohen defined d of 0.8, 0.5 and 0.2 as large, 
medium and small respectively,28 and we applied 
these such as large being d  0.8 and so forth. 
Proportions were compared using the exact z 
pooled test as recommended for small counts 
when expected value was less than 5 for any 
cell.29 Available case analysis was used in the 
presence of missing data. The reported p-values 
are two-sided; to adjust for multiple tests, a p-
value of  0.01 was regarded significant when 
analyzing of the total battery of the 
neuropsychological tests, and otherwise -level 
of 0.05 was applied. Statistical analyses were 
performed using the statistical software SPSS for 
Windows, version 16.0 (Copyright SPSS.Inc, 
1995-2009), except exact unconditional tests 
performed by http://www.stat.ncsu.edu/exact/  
RESULTS
Demographic and injury-related 
characteristics of the patients and the control 
participants are presented in Table 1 and 2. In 
one case of severe TBI, duration of PTA could 
not be assessed due to long lasting sedation not 
related to the TBI.  
Neuroimaging 
All patients were examined with MRI except 
one, who had cortical contusions depicted with 
computed tomography (CT). One of the 62 
patients had no lesions in the brain parenchyma 
when examined with MRI 21 days post-injury. 
This patient had a moderate injury with four days 
of PTA, and multiple contusions and 
subarachnoid hemorrhage on the initial CT scan. 
Thus, all patients had definite TBI, and 71 % had 
diffuse axonal injury detected with MRI.  
Intellectual abilities 
Subjects with TBI had significantly lower 
verbal, performance and total IQ than control 
participants (p < 0.001). Women with TBI had 
significantly higher total IQ scores than men with 
TBI (p=0.02), and performed in the similar range 
as the controls. Among controls there was no 
difference between genders (p=0.34). Severity of 
injury did not significantly affect IQ (Table 2). 
Test performance and effect sizes  
Raw scores were impaired in subjects with 
TBI compared to control participants across all 
cognitive domains (Table 3). All measures of 
information processing speed and verbal memory 
were significantly impaired in patients compared 
with controls. Within the remaining domains, 
significant differences in mean performance were 
shown only for some of the measures, except for 
working memory, where no significant 
differences were found.  
Effect sizes for significant differences were 
medium to large and typically larger when the 
variance in the control group was used for 
standardization.  
Frequency of impairments according to 
normative data  
Table 4 displays the proportions of patients 
scoring in the impaired range according to 
normative data for each test; with cut-off 
criterion of 1.5 SD. Across all tests, 2 % - 44 % 
of the subjects with TBI had clinically impaired 
scores in contrast to 2 %-6% among controls. The 
tests of information processing speed, Grooved 
Pegboard and the delayed recall tasks of the 
CVLT had the highest proportion of impaired 
scores while they also yielded very few impaired 
scores in the control group. On several executive 
tasks, as well as on the working memory task and 
the CCPT measures, no significant difference in 
frequency of impairment was found between the 
groups.  
Cognitive functioning in subgroups of patients 
according to severity of injury  
To study subgroups of patients, we chose 
nine tests, across all the domains, that are 
frequently used in clinical practice, and that in 
the preceding analyses were associated with large 
effect sizes or good ability to discriminate 
patients and controls: Grooved Pegboard; 
dominant hand, CWIT; color naming and 
inhibition/switching, VF; letters, TMT; number 
sequencing and number-letter switching, SDMT; 
written, CVMT; hits and CVLT; delayed recall. 
Table 6 shows number of impaired scores 
(standardized test score below 1.5 SD) out of the 
nine tests. In the healthy volunteers, 98 % had 0-
1 impaired score, which was subsequently 
evaluated as normal performance in this sample, 
whereas having  2 impaired scores was 
evaluated as cognitive impairment. 
Severe and moderate TBI  
Test performance of moderate and severe 
TBI is shown in Table 5.  Mean dpooled for the 
normally distributed tests (Grooved Pegboard; 
dominant hand, VF; letters, CWIT; color naming 
and SDMT; written) was 0.64 for moderate and 
0.95 for severe TBI.  
Of those with moderate injury, 43 % 
demonstrated cognitive impairment, as did 65 % 
of subjects with severe TBI (p=0.09). 
Test performance in relation to PTA duration 
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The subjects with PTA < 1 week performed 
significantly worse than control participants on 
the TMT; numbers and TMT switching, and 
CWIT; inhibition/switching (p-values < 0.001, 
0.007 and 0.013 respectively), with EScontrol of 
1.4, 1.0 and 1.0.  For the remaining six tests, no 
significant difference was found.  
In subjects with PTA of  1 week, 
differences were all highly significant (p0.001), 
and effect sizes were large for all tests ranging 
from 0.9-2.1, except for the CVMT; hits with 
medium effect size of 0.67.  
Eleven of the 30 subjects (37 %) with PTA < 
1 week and 22 of 32 (69 %) with PTA  1 week 
had 2 impaired test score among the nine tests 
shown in Table 5 (p=0.015). (Data regarding 
PTA are not shown.)  
Concurrent functional outcome 
GOSE score was  7 in 20 (69 %) of subjects 
with 0-1 impaired test scores, in 17 (85 %) of 
those with 2-3 impaired scores and in 7 (85 %) of 
subjects with 4-9 impaired scores.  
Functional outcome at 12 months post-injury 
Follow-up GOSE scores at 12 months were 
available for 61 subjects with TBI. GOSE score 
was  7 in 43 % in the group with 0-1 impaired 
score, in 75 % of subjects with 2-3 impaired 
scores and in 73 % of subjects with 4-9 impaired 
scores. The difference in proportion of GOSE 
score  7 between those with 0-1 impaired score 
and those with  2 impaired scores was 
significant (p=0.017). 
The proportion of subjects with GOSE score 
 7 was higher when TBI was severe (75 %) than 
moderate (49 %) (p=0.044) and also higher in 
subjects with PTA of  1 week (83 %) than in 
those with PTA < 1 week (47 %) (p=0.040).  
DISCUSSION 
We studied neuropsychological test 
performance in a neurosurgical cohort of patients 
three months after moderate and severe TBI; with 
parenchymal lesions demonstrated with MRI in 
virtually all cases. Subjects with TBI performed 
worse than control participants in almost all 
domains, with largest effect sizes for speed 
dependent tests. When the injury was moderate, 
however, the majority of the subjects had 0-1 
impaired score out of nine of the most sensitive 
tests, and even after severe injury, this was found 
in one third. Having  2 impaired scores was 
associated with later GOSE score  7, but this 
outcome was also experienced by almost half of 
the subjects with 0-1 impaired score.  
Effect sizes of TBI and sensitivity of tests 
We found that the effect sizes were medium 
to large and varied with the method of 
computation; EScontrol being larger than dpooled, 
and thus confirmed the findings of Schretlen and 
Shapiro. However, even when effect sizes are 
large, overlap between groups is considerable. 
For example dpooled of 0.8 and 1.5 yields overlap 
between groups of 53 % and 29 % respectively,30 
which is incompatible with high sensitivity as 
well as specificity.   
We used 1.5 SD as cut-off level for 
evaluation of the standardized scores, which 
corresponds to 5 % rate of impairment in healthy 
subjects (false positives). The control group 
performed fairly well in line with that, and thus 
the tests demonstrated high specificity to TBI 
with this definition of impairment. But the 
sensitivity to TBI was low, as no test indicated 
impairment for more than 44 % of the patients. 
Hence, there is a need for new test paradigms or 
other methods of examinations with higher 
discriminative abilities. Reitan et al. argued that 
typical neuropsychological tests with continuous 
score distribution should be supplemented by 
tests identifying specific deficits as present or 
absent; yielding a dichotomous distribution.31 
They presented promising results with rather few 
false negative tests in a sample of subjects with 
mixed brain injuries by use of an alternative set 
of tests. Yet, the applicability in patients with 
TBI is unknown. 
Seemingly, a substantial proportion of the 
subjects with TBI had recovered their cognitive 
capacity at this early stage, a course of recovery 
previously demonstrated for mild TBI.9, 32 Still, 
69 % of the subjects with 0-1 impaired score had 
concurrent GOSE score  7, indicating that 
injury-related problems were present. If cognitive 
dysfunction mediates the functional problems, 
which has previously been demonstrated,33, 34 this 
supports the raised concern about low ecological 
validity of common neuropsychological tests.35 
On the other hand, injury-related factors other 
than impaired cognition, like pain or affective 
symptoms might also contribute to their 
functional decline.  
Test performance in relation to injury severity 
Subjects with moderate TBI had significantly 
lower test scores than controls. Dikmen et al. 
reviewed cognitive outcome more than 6 months 
post injury, and concluded that the evidence of 
cognitive dysfunction after moderate TBI was 
“limited and suggestive”.1 In the present study 
we have demonstrated that moderate TBI clearly 
affects cognition three months post-injury, and 
 6 
future studies are needed to explore the cognitive 
outcome in moderate TBI later in recovery. We 
included patients with GCS score 13, a score 
defining mild TBI in some previous studies. 
However, all but one of these had PTA duration 
>24 hours, and thus would have been classified 
as moderate TBI according to several 
recommendations.36, 37 Furthermore, there is an 
increasing trend to classify patients with GCS 
score 13 as moderate TBI.38  
An important finding was that more than half 
of the subjects with moderate TBI performed 
comparable to healthy controls using normative 
data. Consequently, these are persons with 
definite and recent TBI, but whose 
neuropsychological assessment might be 
described as normal as early as three months 
post-injury.  
PTA duration may serve as an alternative 
indicator of injury severity in patients with 
missing GCS score. In this sample, a cut off level 
of PTA at 1 week, divided the subjects with TBI 
into equally large groups with different cognitive 
functioning and different outcome.  
Test performance in relation to MRI findings 
Diffuse axonal injury was found in 71 % of 
TBI cases. DAI has previously been related to 
impairments of information processing speed,39 
executive functions and verbal memory.40, 41 
However, in some of these studies the diagnosis 
of DAI was based on CT characteristics, which is 
not optimal,39, 40 or cases of DAI were not 
compared to cases without DAI.41 The findings in 
our study support that DAI may be an important 
explanation to the large effects on measures of 
speed that was found in this study. Few patients 
had no evidence of DAI in our study, and 
variances in test performance were large. Thus, 
power was not sufficient to compare cases with 
and without DAI, but hopefully, this will be 
explored in a future, larger study.   
Test performance in relation to cognitive 
domains and evaluation of measures  
The speed dependent tests, like the TMT, 
SDMT and CWIT, showed the largest effect sizes. 
Impairments demonstrated by these tests were 
specific to TBI as 20-30 percent of the subjects 
with TBI, but very few control participants 
performed in the impaired range. The most 
sensitive test was  SDMT, but even for this test, 
reported to be “extremely sensitive” to brain 
insults,6 the percentage of the subjects with TBI 
with test performance below 1.5 SD was only 
30 % for the oral version, and 44 % for the 
written version.  
The measures of working memory; digit span 
backwards and letter-number sequencing, were 
surprisingly insensitive to TBI. Possible, these 
tests measure working memory constructs that 
are only mildly affected by TBI, and that tests 
requiring more simultaneous processing, like the 
n-back paradigms,42 might be more useful in 
future studies of working memory deficits 
following TBI.  
In visual memory, measured as CVMT total 
score, we found very similar results in both 
groups. This was due to a higher rate of false 
alarms among the control participants than 
reported in the normative sample.20 Given the 
generally strong abilities of our control group, 
this is difficult to explain. In a study of criterion 
validity of the CVMT in moderate to severe TBI, 
the authors concluded that the CVMT was 
clinically useful, but they did not make any 
comparisons to the normative data.43   
The Conners’ CPT also failed to discriminate 
well between subjects with TBI and control 
participants. Other CPT measures have been 
found to be sensitive to dysfunction of the 
attention system44. Thus, possibly the Conners’ 
CPT-II is less useful than other CPT’s in TBI 
patients. However, our finding may also support 
previous research demonstrating relatively 
preserved vigilance after TBI.45 
Cognitive functioning in relation to one year 
functional outcome 
We found a high frequency of complaints or 
disability one year post-injury in subjects with 
cognitive impairment three months post-injury, 
which was expected as it has been demonstrated 
in previous studies.46 Thus, we confirmed that 
cognitive impairments in the early phase may be 
regarded a risk factor for future complaints. On 
the other hand, a significant proportion, 43 %, of 
those with a normal early assessment experienced 
later complaints. 
Study limitations 
We might have included measures of 
symptom validity since many subjects with TBI 
were injured in traffic accidents and eventually 
will be involved in litigation. However, if poor 
effort was present, we would presumably have 
found a falsely high rather than low sensitivity of 
the tests.  
PTA duration should preferably have been 
evaluated with a validated measure. In our 
neurosurgical cohort, however, with several 
discharge destinations, this would have been 
impractical and associated with inaccurate or 
missing data.  
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Subjects with TBI had significantly lower 
intellectual abilities than the control participants. 
First, this may demonstrate an adverse effect of 
TBI to these functions, which has also previously 
been found.47 The high scores among the women 
with TBI argue against this as the sole 
explanation. Most of our controls and patients 
were manual workers or had work positions 
outside the academic field, but still, there seems 
to be some underlying differences. Recruitment 
of control group has been challenged in TBI 
research,1, 9 but there is no general agreement on 
the method of choice.  
CONCLUSIONS
Persons with TBI were cognitively impaired 
compared to a healthy control group, and 
cognitive impairments at three months were 
associated with later complaints or disability. We 
demonstrated a fair specificity of impairments 
below 1.5 SD, as this was seldom found in the 
control group. On the other hand, the sensitivity 
to TBI of a conventional assessment was low, 
and from a clinical perspective, we consider this 
an important finding. A seemingly normal 
assessment was common in patients with recent 
TBI, confirmed by MRI findings, yet their risk of 
future problems was considerable.  
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Table 1: Demographic, injury-related and outcome variables in  
individuals with moderate and severe TBI. 
 
Variable n No. of Cases (%)* 
Age at testing; years (SD) 63 29.5 (14.3) 
Male / female (%) 63 46 (73) / 17 (27) 
Days post injury; mean (SD) 63 98.2 (10.6) 
GCS score; mean (SD) † 63 9.3 (3.2) 
Moderate / severe injury (%) 63 37 (59) / 26 (41) 
PTA < 1 week / PTA  1 week‡ 62 30 (48) / 32 (52) 
Mechanism of injury 63  
     Fall  21 (34) 
     Traffic accident  36 (57) 
     Other  6 (10) 
MRI examination 62§  
     No findings  1 (2) 
     Pure DAI   14 (23) 
     Cortical contusions  17 (27) 
     DAI and contusions  30 (48) 
GOSE score at testing 62‡  
     8  14 (22) 
     7  3 (5) 
     6  15 (24) 
     5  28 (45) 
     4  1 (2) 
     3  1 (2) 
GOSE score at follow-up 61§§  
     8  25 (41) 
     7  13 (21) 
     6  12 (19) 
     5  11 (18) 
Abbreviations: TBI, Traumatic Brain Injury; SD, Standard Deviation; GCS, Glasgow Coma Scale; 
MRI, Magnetic Resonance Imaging; DAI, Diffuse Axonal Injury; GOSE, Glasgow Outcome Scale 
Extended 
*unless otherwise stated; † Exact GCS score available in 59 cases; ‡ Data not available in one case; 
§one patient not examined with MRI; §§Data not available in two cases. 
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Table 6: Relative frequency of impaired test scores out of nine tests according to 
normative data. Number of patients and controls (%) 
 
Number of low  
test scores* 
Moderate TBI 
(n=37) 
n (%) 
Severe TBI 
(n=26) 
n (%) 
Controls 
(n=48) 
n (%) 
0 13 (35) 5 (19) 36 (75) 
1 8 (22) 4 (15) 11 (23) 
2-3 10 (27) 10 (39) 1 (2) 
4-5 6 (16) 3 (12) 0 
6-7 0 1 (4) 0 
8-9 0 3 (12) 0 
Abbreviations: SD, standard deviation;  
*standardized test scores < 1.5 SD 
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APPENDIX 1 
 
MARSHALL CT CLASSIFICATION 
(Marshall et al. 1991) 
 
Category Definition 
Diffuse injury I  
(no visible pathology) 
No visible intracranial pathology seen on CT scan 
Diffuse injury II Cisterns are present with midline shift 0-5 mm and/or 
lesions densities present; no high or mixed density 
lesion > 25 cc. May include bone fragments and 
foreign bodies 
Diffuse injury III 
(swelling) 
Cisterns compressed or absent with midline shift 0-5 
mm; no high or mixed density lesion > 25 cc. 
Diffuse injury IV (shift) Midline shift > 5 mm; no high or mixed density lesion 
> 25 cc. 
Evacuated mass lesion Any lesion surgically evacuated 
Nonevacuated mass lesion High or mixed density lesion > 25 cc, not surgically 
evacuated 
 
 
  
 
2 
APPENDIX 2 
 
 
THE ROTTERDAM CT CLASSIFICATION  
(Maas, Hukkelhoven, Marshall and Steyerberg. 2005) 
 
PREDICTOR VALUE SCORE 
Basal cisterns  
Normal 0 
Compressed 1 
Absent 2 
Midline shift  
No shift, or shift  5 mm 0 
Shift > 5mm 1 
Epidural mass lesion  
Present 0 
Absent 1 
Intraventricular blood or tSAH1  
Absent 0 
Present 1 
Sum score2 + 1 
1 tSAH; traumatic subarachnoid haemorrhage 
2 The authors chose to add plus 1 to make the grading numerically consistent with the 
grading of the motor score of the GCS and with the Marshall CT classification. 
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APPENDIX 3 
GOS AND GOSE 
 
 
 
Glasgow Outcome Scale Extended
GOS-E
1 Death
2 Vegetative state
3 Lower severe disability
4 Upper severe disability
-------------------------------------------------
5 Lower moderate disability
6 Upper moderate disability
7 Lower good recovery
8 Upper good recovery
Glasgow Outcome Scale
GOS
1  Death
2 Vegetative state
3  Severe disability
Dependent in daily living
----------------------------------------------------
4 Moderate disability
Independent in daily living, but unable
to participate at previous level at work, 
socially or with family
5 Good recovery
No restrictions in work, but small
changes in social, leisure and familiy
life or symptoms may exist
Favourable
outcom
e
Pooroutcom
e
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ERRATA 
 
In Paper I; Author list:  
The correct name of the second author is Tom Ivar Lund Nilsen. (Not Tom Ivar 
Lund; as was printed in the paper) 
 
Chapter 7; page 62; under Paper II and III, second paragraph should be: depth of 
lesion in the MRI was associated with outcome in severe head injury, and…. 
 
Table 3, paper I: total n should be 83, not 84. 
 
Table 4, paper IV: CCPT; hit RT SE by ISI was listed twice as variable name. The 
correct should be first CCPT; hit RT by ISI, and beneath that: CCPT; hit RT SE by 
ISI. 
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